






METTL1 promotes let-7 microRNA processing via m7G methylation  
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N7-methylation of guanosine (m7G) occurs at mRNA caps and at defined internal positions 
within tRNAs and rRNAs. However, its detection within low abundance mRNAs and microRNAs 
(miRNAs) has been hampered by lack of sensitive detection strategies. Here, we adapt a 
chemical reactivity assay to detect internal m7G in miRNA. Using this technique (BoRed-Seq) 
alongside RNA immunoprecipitation, we identify m7G within a subset of miRNAs that inhibit cell 
migration. We show that the METTL1 methyltransferase mediates m7G methylation within 
miRNAs and that this enzyme regulates cell migration via its catalytic activity. Using refined 
mass spectrometry methods, we map m7G to a single guanosine within the let-7e-5p miRNA. 
We show that METTL1-mediated methylation augments let-7 miRNA processing by disrupting 
an inhibitory secondary structure within the pri-miRNA. These results identify METTL1-
dependent N7-methylation of guanosine as a new RNA modification pathway that regulates 













Post-synthesis covalent modification of biological molecules is a key aspect of intracellular 
signaling, and it is critically important in many biological processes. RNA molecules, similarly to 5 
proteins, are subject to a vast array of post-synthesis covalent modifications, which together 
constitute the 'epitranscriptome'. To date, over 100 RNA modifications have been identified, 
which are spread throughout every class of RNA and are evolutionarily conserved throughout all 
kingdoms of life (Carell et al., 2012; Machnicka et al., 2013). 
 10 
RNA modifications have the potential to affect all RNA processes, including splicing, stability 
and localization (Roundtree et al., 2017). Many RNA modifications have been identified by mass 
spectrometry (MS), and complex epitranscriptomes of tRNA and rRNA have been thoroughly 
studied. However, this represents a mere snapshot of a much bigger picture, with the clear 
majority of modifications remaining uncharacterized. This is predominantly due to a lack of 15 
sensitive methodologies with which to detect the modifications at a high resolution. Even now, 
MS methodologies are largely unable to generate transcriptome-wide modification profiles. On 
the other hand, however, a few very recent analyses have employed anti-modification 
antibodies (e.g. against N1-methyladenosine (Dominissini et al., 2016), N6-methyladenosine 
(Dominissini et al., 2012) and 5-hydroxymethylcytosine (Delatte et al., 2016)) or chemical 20 
reactivity of the modification (for pseudouridine (Carlile et al., 2014; Schwartz et al., 2014), m5C 
(Schaefer, 2015) and 2’-O-methylation (Dai et al., 2017)). Their results clearly suggest that 
many modifications identified on rRNA and tRNA are also present on other RNA classes. 
Therefore, the development of epitranscriptomic methodologies (e.g. new antibody and 
chemical methods coupled to next-generation sequencing (NGS)) represents a bottle-neck in 25 
deciphering the function of new RNA modifications. 
 
Certain nucleotides, such as N7-methylguanosine (m7G), display specific modification-
dependent chemistries that can be exploited to study their prevalence and transcript location. 
m7G is present in eukaryotic mRNA 5' caps as well as at defined internal positions within tRNAs 30 
and rRNAs across all domains of life. The best characterized enzyme mediating internal m7G 
methylation is the TRMT8 yeast enzyme homolog METTL1 (Methyltransferase Like 1) which, 
together with its co-factor WDR4 (WD Repeat Domain 4), catalyses m7G at G46 of specific 







In contrast to deoxy-m7G, m7G in RNA is highly stable in neutral aqueous solution (Kriek and 
Emmelot, 1964). Interestingly, the methylation significantly alters the charge density of RNA, 
potentially serving as a molecular handle, but it does not impair Watson-Crick G:C base 
complementarity. It does however, interfere with non-canonical base pairing (i.e. Hoogsteen 
pairs), possibly affecting RNA secondary structure. Although relatively abundant, m7G has 40 
proved very difficult to study so far. Being neutral to Watson-Crick base pairing, it does not 
interfere with reverse transcription, rendering it invisible to detection by standard sequencing-
based technologies.  
 
miRNAs are short single stranded RNA molecules (18–24 nucleotides) that target the RNA 45 
interference silencing complex (RISC) to specific messenger RNAs (mRNAs). Their specificity is 
mediated by partial base-pairing to sequences predominantly found in the 3′ untranslated region 
(3′-UTR) of mRNAs (Bartel, 2009). This interaction results in decreased translation of the 
proteins they encode and/or in the degradation of the mRNAs themselves (Fabian et al., 2010; 
Ghildiyal and Zamore, 2009). To date, over 1000 human miRNAs have been identified, and they 50 
are key regulators of numerous physiological and pathological processes.  
 
miRNA biosynthesis is complex and involves a multi-step pathway that can be regulated at 
many levels (Bartel, 2018) including post-transcriptional modification of miRNA precursors 
(Alarcón et al., 2015; Xhemalce et al., 2012). miRNAs are synthesized from larger transcripts by 55 
RNA polymerase II or III. These pri-miRNAs are then cleaved by DROSHA to release hairpin-
shaped RNAs called pre-miRNAs (Lee et al., 2003) and further cleaved by DICER to generate a 
miRNA duplex (Chendrimada et al., 2005). Certain miRNAs can form alternative secondary 
structures, such as G-quadruplexes, that can interfere with their processing (Mirihana 
Arachchilage et al., 2015; Pandey et al., 2015). However, little is known about the biological 60 
relevance of these structures in a physiological context. 
 
Here, we develop two different but complementary high-throughput sequencing strategies to 
identify miRNAs harboring internal m7G modification. We show that METTL1 methylates a 
specific subset of tumor suppressor miRNAs, including let-7, to promote their processing from 65 
primary transcript to precursor miRNA. Depletion of METTL1 causes gene expression and 
phenotypic changes in a miRNA-dependent manner. We show that m7G-modified miRNAs have 






within let-7e-5p and we show that methylation at this position affects G-quadruplex formation, 




In order to detect N7-methylguanosine within low-abundant RNAs, we adapted an existing 
strategy (Zueva et al., 1985) to allow profiling of internal m7G in eukaryotic RNAs. In this 75 
reaction, m7G residues are prone to nucleoside hydrolysis when reduced by treatment with 
NaBH4. The resulting abasic sites can be revealed by aniline-induced cleavage of the RNA 
chain by β-elimination. This reaction is the basis of direct RNA sequencing by the Maxam & 
Gilbert method (Peattie, 1979), and has been used for mapping m7G residues in highly 
abundant rRNA and tRNA at single nucleotide resolution (Zueva et al., 1985). We optimized the 80 
reaction conditions for reduction of mammalian total RNA in the absence of methylated carrier 
RNA, which would interfere with NGS analysis. As proof of principle, reduced 18S rRNA was 
cleaved by aniline treatment into two fragments, in agreement with the known position of m7G 
(Piekna-Przybylska et al., 2007; Figure S1A).  
 85 
The above strategy is not suitable for very short RNAs, like miRNAs, because the resulting 
cleavage fragments would be too small to be unequivocally mapped to the human 
transcriptome. Therefore, we developed a new protocol, based on the above, to detect m7G 
within miRNAs, which we refer to as BoRed-Seq (Figure 1A). Total RNA from a human lung 
cancer cell line (A549 cells) was decapped, 5'-end dephosphorylated, treated with NaBH4 and 90 
exposed to low pH to generate abasic sites at positions harboring m7G. These sites were 
exposed to a biotin-coupled aldehyde reactive probe (N-(aminooxyacetyl)-n'-(D-biotinoyl) 
hydrazine; ARP) that covalently binds to abasic RNA sites (Tanaka et al., 2011). Modified RNAs 
were then pulled-down using streptavidin-beads, small RNA libraries were prepared and RNAs 
were identified by high-throughput sequencing. Using this approach (Figure 1B), a number of 95 
mature miRNAs likely to contain m7G were identified (Table S1). 
 
To confirm the validity of this technique and to provide an independent verification of m7G-
methylated miRNAs, we performed a RIP-Seq experiment employing an antibody that 
recognizes m7G in RNA (Figure 1C). This antibody immunoprecipitates m7G-containing RNAs, 100 






and it specifically enriches m7G-containing 18S rRNA and tRNAs (Figure S2A,B). RIP-Seq with 
this antibody identified a second cohort of mature miRNAs containing m7G (Table S2). 
 
We then compared the results from the BoRed-Seq and RIP-Seq approaches and found there 105 
was a significant overlap of m7G-modified miRNAs detected by each technique (upper right 
quadrant, Figure 1E; Figure S2C,D). We regard these miRNAs as high confidence m7G-
modified miRNAs (Table S3), five of which were validated by RIP-qPCR analysis (Figure 1F). 
m7G is found on miRNAs of any abundance, bearing no correlation with any particular 
expression level (Fig. S2E). 110 
 
We extended these analyses to an unrelated colorectal cancer cell line (Caco-2 cells), which 
expresses METTL1 at levels comparable to those observed in A549 cells. This identified 
significantly overlapping m7G-modified miRNAs (Figure 1G and S2F; Table S4), suggesting that 
m7G modification of miRNAs is a general and conserved phenomenon. 115 
 
Deposition of m7G in tRNA is catalysed, at least in part, by METTL1. We therefore asked 
whether any of our high confidence m7G-containing miRNAs are affected by METTL1 depletion. 
Knockdown of METTL1 in A549 cells (Figure 1H; Figure S2G) followed by small RNA 
sequencing revealed that significantly down-regulated miRNAs are more enriched in m7G, 120 
compared to miRNAs that are up-regulated or unchanged (Figure 1I; Table S5). Similar effects 
were also observed in Caco-2 cells (Figure S2H). Importantly, the reduced levels of m7G-
containing miRNAs are rescued by expression of wild-type (WT) METTL1 but not by a 
catalytically inactive version (Figure S2I,J) of the enzyme (Figure 1J). 
 125 
Interrogation of the m7G-containing miRNAs down-regulated upon METTL1 knockdown (Table 
1) shows that 50% (10/20) of them have been previously functionally linked to the inhibition of 
cell migration (Zhang et al., 2011). This raised the possibility that METTL1 might control cell 
migration via regulation of a subset of miRNAs, including the let-7 family (Lee and Dutta, 2007). 
To explore this possibility, we first tested whether METTL1 affects migration of A549 cells. 130 
Indeed, knockdown of METTL1 significantly increases their migratory capacity (Figure 2A,B) 
without effecting cellular proliferation (Figure 2C) or overall mRNA translation levels (Figure 
S2K). Notably, the increased migration is rescued by the expression of WT METTL1 but not by 
a catalytically inactive version of the enzyme (Figure S3A). These results suggest that METTL1 







To further explore this possibility, we performed a global gene expression analysis to identify 
transcripts affected by depletion of METTL1 (Figure 2D and Table S6). This revealed 254 up-
regulated and 60 down-regulated transcripts. Strikingly, gene ontology analysis indicates up-
regulation of pathways involved in cellular migration (Figure 2E; Figure S4B-E and Table S7), in 140 
agreement with our phenotypic characterization of METTL1 knockdown cells (Figure 2A,B).  
 
We then asked whether METTL1-regulated transcripts are also targets of the m7G-modified 
miRNAs. In silico predicted mRNA targets for these miRNAs are differentially expressed upon 
METTL1 knockdown, whereas mRNA targets of control miRNAs are not (Figure 2F). We 145 
confirmed these findings using an unbiased approach that identified let-7(5p) seed sequence as 
the most significantly enriched in up-regulated mRNAs (Figure S3F), a number of which are 
individually shown in Figure S3G. Indeed, the presence of the let-7 target sequence within the 
3’-UTR of mRNAs represents the strongest predictive factor for their up-regulation upon 
METTL1 knockdown (Figure S3H). 150 
 
The above results indicate that many of the genes involved in cell migration, and up-regulated 
upon METTL1 depletion, are targets of METTL1-dependent miRNAs. This suggests that 
METTL1 regulates gene expression via control of miRNA function. To investigate this possibility, 
we focused on HMGA2, one of the most up-regulated transcripts following METTL1 depletion, 155 
and whose 3'-UTR is significantly enriched for evolutionarily conserved target sites of several 
m7G-containing miRNAs, including let-7(5p), miR-125(5p) and miR-92(3p) (Figure 3A; 
OR=5.46, P=0.001). First, we confirmed that METTL1 knockdown increases HMGA2 mRNA 
expression and protein levels in both A549 cells (Figure 3B,C) and Caco-2 cells (Figure S4A,B). 
Next, we confirmed that HMGA2 mRNA is not m7G modified itself by performing BoRed-qPCR 160 
and RIP-qPCR (Figure S4C). 
 
To demonstrate that the effect of METTL1 was mediated, at least partly, by a miRNA pathway, 
we generated a stable A549 cell line containing a reporter construct consisting of the 3'-UTR of 
Hmga2 linked to the coding sequence of luciferase. Knockdown of METTL1 in this reporter line 165 
increases luciferase activity, confirming that the 3'-UTR of HMGA2 confers responsiveness to 
METTL1 (Figure 3D,E). To confirm that METTL1 regulation of the 3'-UTR of HMGA2 is 






sites within this 3'-UTR. Deletion of the let-7 seed sequences from the 3’-UTR leads to 
increased luciferase activity and uncouples it from METTL1 regulation (Figure 3E and S4D). 170 
 
Figure 3F shows that introduction of mature let-7e-5p miRNA into A549 cells reduced HMGA2 
protein expression as expected (Mayr et al., 2007). Importantly, transfection of mature let-7e 
miRNA reverts the up-regulation of HMGA2 protein caused by METTL1 depletion (Figure 3F). 
Expression of an shRNA-resistant version of WT METTL1 also reverts HMGA2 up-regulation 175 
due to METTL1 depletion and this requires the catalytic activity of the methyltransferase (Figure 
3G). Together, these data confirm that METTL1 methyltransferase activity regulates expression 
of HMGA2 in a let-7-dependent manner. 
 
We next explored the functional role of let-7 methylation by METTL1. We used UV cross-linking 180 
and immunoprecipitation (CLIP) to confirm in our system previous findings (Bao et al., 2018) 
that METTL1 binds directly to miRNA precursors, including pri-let-7e and pri-miR-125a hairpins 
(Figure 4A and Figure S4E). To date, there are two known methylations of miRNA: m6A 
catalysed by METTL3 (Alarcón et al., 2015) and 5’-phosphate methylation catalysed by 
BCDIN3D (Xhemalce et al., 2012). In both cases, methylation regulates miRNA processing. To 185 
test whether METTL1 might also be involved in such a pathway, we asked whether it regulates 
the processing of m7G-containing miRNAs. Indeed, depletion of METTL1 significantly reduced 
the levels of the pre- and mature forms of let-7e-5p and miR-125a-5p, whereas their primary 
transcripts were unaffected (Figure 4B,C and Figure S4F). This is unlikely to be due to a general 
defect in processing since METTL1 depletion does not affect the levels of various miRNA 190 
processing factors (Figure S4G). 
 
The above findings indicate that METTL1 activity is required for pri- to pre- processing of 
miRNAs, implying that pri-miRNAs are directly m7G modified by METTL1 and the modification 
is subsequently retained through to the mature miRNA (Fig. S4H). Indeed, m7G RIP 195 
experiments show that pri-miRNAs are enriched in m7G, which decreases upon METTL1 
knockdown (Figure 4D and Figure S4I,J).  
 
To further demonstrate the METTL1-dependent effect on miRNA processing we employed an in 
vitro assay (Lee et al., 2002) to test the efficiency of cellular extracts to process a radioactive 200 






precursor transcripts less efficiently than control extracts (Figure S5A). Thus, METTL1 is 
required for efficient processing of target miRNAs such as let-7. 
 
To confirm that pri-let-7e is directly methylated by METTL1, we performed an in vitro 205 
methyltransferase assay using a pre-assembled recombinant METTL1/WDR4 complex (Figure 
S5B) and pri-let-7e hairpin oligonucleotides, tRNAPhe, and an unrelated negative control miRNA 
(cel-miR-67 hairpin), as substrates. Using MS, we detected m7G in let-7e RNA and tRNAPhe but 
not in the control miRNA (Figure 4E and Figure S5C). 
 210 
To directly assess whether m7G affects miRNA processing, we first prepared radiolabeled, m7G 
containing pri-let-7e RNA as shown in Figure 4F. Briefly, radioactive pri-let-7e hairpin RNA was 
methylated in vitro by incubation with METTL1/WDR4 complex and m7G containing RNA was 
enriched via RIP. The resulting methylated and non-methylated (control) pri-miRNAs were then 
subjected to a DROSHA processing assay. The results indicate that m7G methylated pri-let-7e 215 
RNA was more efficiently processed by DROSHA in vitro (Figure 4G).  
 
To probe the mechanism by which m7G methylation of let-7e affects its processing in vivo, we 
sought to identify the position of the methylation site within the let-7e miRNA. We set up spectral 
sequencing of RNA methylation and we applied it to mature miRNAs purified from A549 cells. 220 
This targeted MS method allows the mapping of modification sites within a specific sequence at 
single base resolution. This approach highlighted one methylated guanosine at position 11 
(G11) of let-7e-5p (Figure 5A,B and Figure S5D), which is also required for efficient in vitro 
methylation of let-7e (Figure S5E). 
 225 
G11 is part of a short 16nt-long G-rich sequence of the form G2+N4G2+N4G2+N4G2+, where N is 
any base.  This type of motif is known to fold into the alternative Hoogsteen base-paired G-
quadruplex structure (Kwok et al., 2016a). It is noteworthy that formation of a G-quadruplex 
structure has been documented in three miRNA precursors, namely miR-92b (Mirihana 
Arachchilage et al., 2015), miR-149 (Kwok et al., 2016b), and let-7e (Pandey et al., 2015). 230 
According to our previous results, all of these miRNAs are both m7G-modified and METTL1-
dependent (Table 1), suggesting that G-quadruplex formation may be involved in the regulation 







To explore the connection between G-quadruplexes and m7G, we analysed the base 235 
composition of m7G harboring miRNAs, assessing potential enrichment of G-quadruplex motifs. 
We found that m7G-modified miRNAs are characterised by a bias in nucleotide content toward 
an increased G-richness (Figure S6A) and G-skewness (Figure 5C). These observations 
suggest that m7G harboring miRNAs display sequences with the propensity to form G-
quadruplexes. Moreover, using a G-quadruplex predicting algorithm, we found that miRNAs 240 
containing at least 1 predicted G-quadruplex are significantly enriched in m7G (Figure 5D and 
Figure S6B).  Interestingly, the G-quadruplexes are predicted to fold at a very similar relative 
position within different m7G containing miRNA hairpins (Figure 5E), which overlaps the 5’ site 
of pri-miRNA (DROSHA) cleavage. Overall, these analyses suggest that G-quadruplexes 
contribute to METTL1-mediated regulation of miRNA activity. 245 
 
To support a role for G-quadruplex formation in the processing of pri-let-7e, we carried out a 
biophysical analysis of the short 16nt-long G-rich sequence, referred to as rG4-let-7e. Using 
circular dichroism (CD), we found that the CD spectrum of rG4-let-7e is cation-dependent and is 
characterized by a maximum ellipticity at 263 nm and a minimum at 240 nm (Figure S6C). This 250 
observation is consistent with G-quadruplex formation (Kypr et al., 2009). Denaturation 
experiments revealed a potassium-dependent transition at 48.1°C (Figure S6C). We then 
assessed the ability of this sequence to fold into a G-quadruplex in the context of pri-let-7e. The 
CD spectrum of pri-let-7e also displayed a maximum at 263 nm and a local minimum at 240 nm 
but with an additional minimum at 210 nm indicative of a more complex structure (Figure S6D). 255 
Denaturation experiments of pri-let-7e, followed by CD spectroscopy at 263 or 210 nm in the 
presence of KCl, revealed two transitions indicating the presence of two structures in equilibrium 
(Figure 5F). While the second transition is centred around ~ 75°C and correspond to the 
expected hairpin structure, a first transition was observed at ~ 48°C, similar to the melting 
transition of rG4-let-7e and may correspond to the formation of the rG4-let-7e quadruplex 260 
structure. To support this point, we introduced G to A mutations in pri-let-7e at positions that are 
expected to destabilize the rG4-let-7e quadruplex (Figure S6E). We found that G to A mutants 
display single-phase melting curves with transitions above 70°C (Figure S6F). This result 
demonstrates that G to A mutations in pri-let-7e impede G-quadruplex formation.  
 265 
We hypothesised that m7G might affect the stability of G-quadruplexes in vivo by disrupting the 
N7 H-bonds and Hoogsteen base pairing whilst preserving Watson-Crick base pairing (Figure 






since synthesis of m7G-containing oligonucleotides is currently unavailable and because, like 
m7G, DAG weakens secondary structures supported by Hoogsteen base pairing (Figure 6A; 270 
Rommler et al., 2013). We found that the rG4-let-7e quadruplex structure containing a single G 
to DAG substitution at the G11 position, was significantly less stable than the WT sequence 
(Figure S6C). We then generated G to DAG mutant versions of pri-let-7e (Figure 6B). While the 
D1 and D2 oligonucleotides displayed two G to DAG mutations at G4/G5 and G11/G12 
respectively, one oligonucleotide bears a single G to DAG mutation at position G11. 275 
Denaturation experiments followed by CD spectroscopy were performed to assess the 
quadruplex/stem-loop equilibrium within pri-let-7e and the contribution of each guanosine to pri-
let-7e folding (Figure 6C,D). We observed that mutation of G11 (in both D2 and G11 mutants) 
affects the folding of pri-let-7e by shifting the structural equilibrium toward the canonical stem-
loop structure. In contrast, mutating G4 and G5 (D1 mutant) did not significantly affect the 280 
structural equilibrium. Taken together, these results suggest that methylation of G11 favors the 
stem-loop structure of let-7e. 
 
We next used the DAG-containing pri-let-7e hairpin oligonucleotides to establish whether the 
induced change in structure affects the processing of the precursor RNAs in vivo. We 285 
transfected either WT or the DAG-containing oligonucleotides into A549 cells and we measured 
the levels of mature let-7e-5p by RT-qPCR 72 hours after transfection. Furthermore, we 
transfected D2 and WT oligonucleotides into A549 METTL1 knockdown cells and measured the 
levels of HMGA2 by immunoblotting. Strikingly, in agreement with the biophysical observations, 
the D2 oligonucleotides, containing G11 DAG, were more efficiently processed than either WT 290 
let-7e or D1 oligonucleotides (Figure 6E). Finally, the D2 oligonucleotide effectively rescued 
HMGA2 expression in the absence of METTL1, whereas the WT did not (Figure 6F). Overall, 
our data suggest that methylation of pri-let-7e at G11 promotes its processing via disruption of 




In our current study, we use two independent unbiased techniques to demonstrate that a subset 
of miRNAs harbors internal m7G modification. We find that these are functionally related, tumor 
suppressive miRNAs, and they include the let-7 family. We show that m7G promotes processing 300 
of their precursor RNAs and that METTL1-dependent methylation is required to suppress 






sequence-specific context using RNA purified from cells. This allowed us to pinpoint the 
modification to G11 of the mature let-7e-5p. We show that pri-let-7e can adopt two alternative 
conformations, consistent with a G-quadruplex structure and a canonical stem-loop. The G11 305 
position has previously been implicated in the formation of a G-quadruplex structure (Pandey et 
al., 2015) and we confirm the presence of this G-quadruplex in let-7e. Importantly, we show that 
substitution of G11 with DAG affects the quadruplex/stem-loop equilibrium within pri-let-7e and 
mimics the effects due to m7G. 
 310 
The presence of m7G in miRNAs strongly correlates with their predicted tendency to adopt G-
quadruplex structures. Such structures are known to be inhibitory to miRNA processing 
(Mirihana Arachchilage et al., 2015; Pandey et al., 2015), consistent with our findings that the G-
quadruplex motif in let-7e overlaps the DROSHA cleavage site. Taken together, our data 
suggest a model in which METTL1-mediated deposition of m7G within G-rich regions 315 
destabilizes G-quadruplexes, thereby promoting their processing from pri- to pre-miRNA (Figure 
7). 
 
Whilst this manuscript was under revision, Gregory and colleagues (Lin et al., 2018) reported 
that METTL1 knock-out mouse embryonic stem cells possess defective mRNA translation at a 320 
global level. In our system, by employing an inducible knockdown approach to reduce the levels 
of METTL1, we did not dramatically affect the levels of m7G in tRNAs (Figure S2G). This is 
consistent with our ribosome profiling results in normal versus METTL1-depleted cells, which 
showed no significant effect on overall translation (Fig S2K). Therefore, our inducible approach 
allowed us to dissect new orthogonal, m7G-dependent pathways uncoupling them from tRNA 325 
effects.  
 
G-quadruplexes and other alternative structures involving non Watson:Crick base-pairing have 
been described in other classes of RNA, including mRNA (Bugaut and Balasubramanian, 2012) 
where they are proposed to induce ribosome-stalling, thereby inhibiting translation (Endoh et al., 330 
2013). We speculate that m7G represents a general way of destabilising such structures, 
counteracting their effects. Thus, a comprehensive understanding of the m7G modification 
pathways will be instrumental in deciphering the roles that Hoogsteen-based structures play in 







Only two other miRNA methylations have been identified in miRNAs, m6A and 5'-methyl 
phosphate (Alarcón et al., 2015; Xhemalce et al., 2012). However, these two modifications show 
different features to m7G characterized here. On one hand, m6A enhances processing of many, 
if not all, miRNAs in breast cancer cells, and can be regarded as a general mechanism; this 
methylation promotes binding of DROSHA to the primary miRNA. On the other hand, 5'-methyl 340 
phosphate represses processing of miR-145 by inhibiting binding of DICER to the pre-miRNA. 
Here, we show that m7G promotes miRNA processing in a unique manner, by directly affecting 
the secondary structure of a specific set of pri-miRNAs which share a common functional 
signature, namely suppression of cell migration.  
 345 
The model proposed here could represent a widespread molecular mechanism to safeguard the 
levels and activity of important tumor suppressive G-rich miRNAs. In this scenario, the formation 
of G-quadruplexes is a 'side-effect' of miRNA sequence, and the m7G pathway is required to 
maintain pre-miRNAs in a functional state. Alternatively, but not mutually exclusively, the 
presence of G-quadruplexes itself might represent a novel additional layer of regulation to 350 
control functionally related miRNAs which, for example, inhibit cell migration.  
 
Many mechanisms control cell migration and tumor invasiveness, and one of the most important 
drivers is the AKT oncogenic signaling pathway (Irie et al., 2005). Notably, AKT has been shown 
to directly phosphorylate METTL1 to inhibit its enzymatic activity (Cartlidge et al., 2005). Given 355 
the findings presented here, it is likely that hyperactivation of AKT in cancer would reduce the 
levels of m7G-containing tumor suppressive miRNAs, including the let-7 miRNA family. This 
family in particular inhibits the progression and invasiveness of numerous tumors, including lung 
cancer, by regulating the expression of key oncogenes such as RAS, MYC and HMGA2 
(Balzeau et al., 2017). The control of let-7 family members by the m7G pathway may represent 360 
a common mechanism to modulate their expression and therefore activity. Beyond cancer, let-7 
is implicated in neurodegenerative diseases, such as Alzheimer’s disease, in which it is 
significantly up-regulated (Lehmann et al., 2012). Furthermore, low levels of let-7 have been 
shown to improve tissue repair through reprogramming of cellular metabolism (McDaniel et al., 
2016; Shyh-Chang et al., 2013). Therefore, direct targeting of METTL1 could represent a valid 365 
and unexplored therapeutic strategy in these pathological contexts. 
 
This report identifies the m7G pathway as a novel regulator of miRNA function.  Considering the 
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Main Figure Titles and Legends 
 
Figure 1 | Detection of m7G in specific miRNAs in A549 cells.  
A, Schematic of a novel chemical method to detect internal m7G RNA modification. B, 
Schematic representation of the procedure used to identify the m7G modified miRNAs in A549 400 
cells. C, Immuno dot blot of total decapped INPUT RNA (10%) or RNA immunoprecipitated with 
anti-m7G antibody or control IgG. D, Immunoprecipitation with anti-m7G antibody enriches for 
m7G-containaing RNAs as determined by mass spectrometry (see also Figure S1). The 
average of two biological replicates ± S.D. is shown. E, Scatter plot showing high degree of 
consistence between the BoRed-Seq approach and RIP-Seq in detecting miRNAs harboring 405 
m7G (upper right quadrant). Goodness of fit is calculated as R2 Pearson correlation coefficient. 
F, RNA immunoprecipitation with the anti-m7G antibody coupled to qRT-PCR was used to 
validate five m7G-containing miRNAs and four negative miRNAs, which are identified in panel 
E. The average of four biological replicates ± S.D. is shown. The distributions of mean 
enrichments in m7G-positive and m7G-negative miRNAs are significantly different, as evaluated 410 
by two-tailed Wilcoxon text (*P<0.05). G, Venn diagram showing the overlap between miRNAs 
significantly enriched in m7G-RIP of A549 and Caco-2 cells, respectively (see also Figure S2). 
P-value is obtained by Fisher’s exact test. H, Western blot showing METTL1 protein levels in 
A549 cells infected with METTL1-specific (sh1, sh2) or control (Scramble) TET-inducible 
shRNAs five days after doxycycline treatment. A representative experiment of four independent 415 
biological replicates is shown. I, Box plot showing increased m7G signal (as an average 
enrichment in both BoRed-Seq and m7G-RIP-Seq; panel E) in miRNAs that are significantly 
down-regulated (↓) upon inducible METTL1 knockdown, but not in miRNAs that are unchanged 
(=) or up-regulated (↑). Statistical significance was calculated by Wilcoxon test. J, RT-qPCR 
showing the levels of let-7e-5p and miR-125a-5p in WT and METTL1 knockdown A549 cells in 420 
the presence of either active (+) or catalytically inactive (c.i.) exogenous METTL1 (Ex. 
METTL1). 
 
Figure 2 | METTL1 inhibits cellular migration of A549 cells.  
A, A migration assay was performed for seven hours using cells infected with METTL1-specific 425 
(sh1, sh2) or control (Scramble) TET-inducible shRNAs five days after doxycycline treatment. B, 
Results from panel A were quantitated and plotted as indicated. The plot shows the average of 
six biological replicates ± S.D. (***P<0.001, two tailed t-test). C, A proliferation assay was 






or control (Scramble) TET-inducible shRNAs. The average of four biological replicates ± S.D. is 430 
shown. D, Global gene expression analysis of cells infected with METTL1-specific (sh1) or 
control (Scramble) TET-inducible shRNAs five days after doxycycline treatment. Log2 fold 
change was plotted against average log2 expression. Significantly up-regulated (red) and 
significantly down-regulated (blue) transcripts are indicated. See also Figure S3. E, Gene 
ontology analysis of gene expression changes following METTL1 knockdown identifying up-435 
regulated KEGG pathways involved in cellular migration (in red). F, log2 fold change in 
expression of predicted targets of the indicated miRNAs, upon METTL1 knockdown. Each pair 
of box plots compares the fold change of mRNAs which are targets (red), or not (gray), of a 
single specific miRNA. Statistical significance was calculated by Wilcoxon test. 
 440 
Figure 3 | METTL1 catalytic activity regulates HMGA2 expression in a let-7-dependent 
manner.  
A, Schematic of HMGA2 3'-UTR showing enrichment of evolutionarily conserved target sites of 
several m7G-containing miRNAs (OR=5.46, P=0.001). B, HMGA2 expression was measured by 
RT-qPCR in A549 cells infected with METTL1-specific (sh1, sh2) or control (Scr) TET-inducible 445 
shRNAs five days after doxycycline treatment. The average of six biological replicates ± S.D. is 
shown (***p<0.001, two tailed t-test). C, Western blot showing METTL1, HMGA2 and β-tubulin 
protein levels in A549 cells infected with METTL1-specific (sh1, sh2) or control (Scramble) TET-
inducible shRNAs five days after doxycycline treatment. Two representative biological replicates 
of a total of four are shown. D, Western blot showing METTL1 down-regulation upon 450 
transfection with METTL1 specific siRNAs in A549 cells stably expressing a luciferase cDNA 
with Hmga2 3'-UTR. Two independent transfections of a total of four replicates are shown.  E, 
Luciferase fluorescence levels upon METTL1 down-regulation in A549 cells stably expressing a 
luciferase cDNA with Hmga2 3'-UTR as a reporter. Red and gray bars indicate luciferase levels 
in the presence of either WT Hmga2 3'-UTR or of a variant in which all 7 let-7 seed sequences 455 
have been mutated, respectively. The plot shows the average of four independent transfections 
± S.D. (***P<0.001, two tailed t-test). F, Western blot showing rescue of HMGA2 up-regulation 
upon transfection with let-7e-5p mature miRNA in METTL1 knockdown A549 cells. Two 
independent transfection replicates of a total of four are shown. G, Western blot showing rescue 
of HMGA2 up-regulation upon over-expression of WT, but not catalytically inactive METTL1 in 460 
A549 METTL1 knockdown cells. Two representative biological replicates of a total of five 








Figure 4 | METTL1 directly modifies let-7e pri-miRNA and regulates its processing.  
A, CLIP-qPCR using a METTL1-specific antibody or a non-specific IgG. The levels of 
immunoprecipitated pri-let-7e and pri-mir-125a hairpins are shown. The average of two 465 
independent immunoprecipitation reactions ± S.E.M. is shown (*P<0.05, two tailed t-test). miR-
148a is shown in Figure S4E as a negative control. B, RT-qPCR showing the levels of either 
LET7E/125A primary transcript (blue) or let-7e and miR-125a precursors (gray) upon METTL1 
knockdown in A549 cells. The average of five to six independent biological replicates ± S.D. is 
shown (*P<0.05, **P<0.01, two tailed t-test). C, RT-qPCR quantification of let-7e-5p and miR-470 
125a-5p upon METTL1 knockdown. The average of five independent biological replicates ± S.D. 
is shown (**P<0.01, ***P<0.001, two tailed t-test). miR-148a-3p is shown in Figure S4F as a 
negative control. D, m7G RNA immunoprecipitation and RT-qPCR of LET7A3, LET7B, 
LET7E/125A primary transcripts in A549 cells upon METTL1 knockdown. The average of three 
independent biological replicates ± S.E.M. is shown (*P<0.05, **P<0.01, ***P<0.001, two tailed 475 
t-test). E, In vitro methylation reaction using recombinant METTL1/WDR4 pre-assembled 
complex on let-7e or cel-miR-67 primary hairpin (negative control). Mass spectrometry analysis 
shows specific m7G methylation of let-7e hairpin. The average of three independent 
experiments ± S.D. is shown. F, Experimental strategy to obtain radiolabeled, m7G modified pri-
let-7e (IVm7G-pri). Histogram shows the fraction of RNA recovered by m7G-RIP after in vitro 480 
methylation with METTL1/WDR4, as evaluated by scintillation counting (***P<0.001, two tailed t-
test). G, In vitro processing assay of pri-let-7e: control (Ctrl) or in vitro methylated pri-miRNAs 
were incubated in the presence of immunoprecipitated DROSHA. Autoradiography reveals that 
IVm7G-pri undergoes more efficient processing, yielding the expected cleavage pattern shown 
in the cartoon. Histogram shows the relative quantification of the resulting pre-let-7e from four 485 
samples obtained in two independent experiments (*P<0.05, two tailed t-test). Autoradiography 
images are composite of different molecular weight regions and exposure times. Full, 
unprocessed images are deposited on Mendeley Data. See also Figure S5. 
 
Figure 5 | G-quadruplexes mark m7G-containing miRNAs.  490 
A,B, Spectral sequencing of in vivo let-7e-5p showing unmodified (A) and methylated 5'-
AGGAGGU-3' fragment (B), obtained following RNAse A digestion of a miRNA fraction isolated 
from A549 cells (see also Figure S5). C, Box plot showing the maximum G-score, a quantitative 
estimation of G-richness and G-skewness (see Methods for a definition), in primary hairpins of 






the enrichment of miRNAs, grouped according to the propensity of their primary hairpins to form 
G-quadruplexes (***P<0.001, Wilcoxon test). E, Metagene plot showing pri-miRNA cleavage 
site distribution (top panel) and the predicted stability of G-quadruplexes (middle panel) and 
double strand (bottom panel) across primary hairpins of unmodified (gray) or m7G-modified 
miRNAs (blue). F, Denaturation experiments of let-7e primary hairpin in the presence of 100 500 
mM KCl followed by circular dichroism at 263 or 210 nm show two transitions demonstrating 
that let-7e exist as a mixture of two distinct structures in equilibrium in solution (top cartoon). 
The first structure melts at 48.5–50.6°C, while the second one is more stable (75.9–73.6°C). G, 
Scheme showing the predicted G-quadruplex (rG4, pink) within the pri-let-7e hairpin. In red are 
shown the guanosines predicted to be involved in the formation of the quadruplex motif. Arrows 505 
mark the cleavage sites of let-7e-5p processing. Asterisk indicates the position of m7G. See 
also Figure S6. 
 
Figure 6 | m7G position is essential for let-7e quadruplex/stem-loop equilibrium and 
promotes miRNA processing.  510 
A, Schematic representation of a guanine tetrad, highlighting Hoogsteen-base pairing involving 
the N7 of guanosine that stabilize G-quadruplex structure, together with a stabilising monovalent 
cation (M+, usually potassium). Both 7-methylguanosine and 7-deazaguanosine are able to 
destabilize the hydrogen bond involving N7. B, Cartoon depicting the pri-miRNA hairpins 
employed in the following experiments. C, Thermal denaturation studies of RNA 515 
oligonucleotides as described in B. While GG to DAG/DAG mutation at the D1 position does not 
significantly affect the contribution of G4 in the G4/stem-loop equilibrium, GG to DAG/DAG 
mutation at the D1 position and a single G11 to DAG mutation affect the contribution of rG4 in 
the structural equilibrium by shifting it towards the hairpin form. D, First derivative plot of the 
denaturation experiment in C helps visualizing the decrease in rG4 contribution to the 520 
equilibrium (red arrow). E, RT-qPCR showing the levels of let-7e-5p seventy-two hours after 
transfection with either WT, D1, D2 or G11 oligonucleotides. The average of six independent 
transfections ± S.D. is shown (**P<0.01, ***P<0.001, two tailed t-test). F, Western blot showing 
rescue of HMGA2 up-regulation upon transfection of D2, but not WT let-7e primary hairpin in 
A549 METTL1 knockdown cells. Two representative biological replicates of a total of three 525 









Figure 7 | Role of m7G in miRNA biogenesis. 530 
Proposed model of the role of METTL1-mediated m7G in promoting miRNA processing and 







 BoRed-Seq m7G-RIP-Seq 
miRNA Log2Enrich FDR Log2Enrich FDR 
hsa-let-7a-5p (im) 3.793 1.47E-35 0.923 7.05E-12 
hsa-let-7b-3p 3.650 5.36E-20 0.923 1.26E-11 
hsa-let-7b-5p (im) 3.848 5.38E-40 1.756 1.25E-27 
hsa-let-7c-5p (im) 4.049 6.87E-39 1.128 4.61E-15 
hsa-let-7e-5p (im) 3.357 5.77E-30 2.149 6.00E-32 
hsa-miR-125a-5p (im) 0.921 3.76E-03 0.575 3.46E-03 
hsa-miR-149-3p 3.227 2.37E-02 2.306 3.03E-14 
hsa-miR-193a-5p 1.673 8.71E-03 0.743 9.27E-04 
hsa-miR-23b-5p (im) 2.490 6.78E-06 2.789 3.32E-54 
hsa-miR-320a (im) 1.924 4.26E-11 1.336 1.07E-14 
hsa-miR-320b (im) 2.568 6.54E-16 1.740 7.94E-54 
hsa-miR-320c (im) 3.465 1.81E-20 2.066 3.88E-50 
hsa-miR-320d 2.968 1.84E-09 2.217 4.53E-59 
hsa-miR-320e 2.794 1.15E-02 1.460 1.89E-09 
hsa-miR-328-3p 1.669 8.85E-03 1.260 2.17E-15 
hsa-miR-505-5p 2.830 3.12E-02 2.274 1.52E-13 
hsa-miR-663a (im) 6.671 3.23E-43 1.106 7.60E-04 
hsa-miR-760 3.142 5.18E-04 2.258 1.93E-31 
hsa-miR-92b-3p 2.416 7.64E-14 1.459 1.72E-27 
hsa-miR-92b-5p 4.302 1.06E-30 0.805 1.84E-07 
 
Table 1 | miRNAs harboring METTL1-dependent m7G. Table shows m7G-modified miRNAs 
(from Figure 1E) whose expression is down-regulated upon METTL1 knockdown. miRNAs 














STAR Methods 540 
 
CONTACT FOR REAGENT AND RESOURCE SHARING  
Queries and reagent requests may be directed and will be fulfilled by the lead contact, Tony 
Kouzarides (tony.kouzarides@gurdon.cam.ac.uk) 
 545 
EXPERIMENTAL MODEL AND SUBJECT DETAILS  
 
Cell lines 
HEK-293T (RRID:CVCL_0063) and A549 cells (RRID:CVCL_0023) were cultured in DMEM 
(Invitrogen), supplemented with 10% fetal bovine serum (FBS) and 1% 550 
penicillin/streptomycin/glutamine (PSQ). Caco-2 cells (RRID:CVCL_0025) were cultured in 
Eagle's Minimum Essential Medium, supplemented with 20% FBS and 1% PSQ. Cell lines were 
obtained from the ATCC and tested negative for mycoplasma contamination. Human cell lines 
used are not listed in the cross-contaminated or misidentified cell lines database curated by the 
International Cell Line Authentication Committee (ICLAC). 555 
 
Lentiviral vector preparation and cell transduction 
For virus production, HEK-293T cells were transfected with the lentiviral vector pLKO-TETon-
Puro for METTL1 knockdown, or Zs-Green-HIV for METTL1 rescue experiments, together with 
the packaging plasmids PAX2 (Addgene Plasmid #12260) and pMD2.G (Addgene Plasmid 560 
#12259) at a 1:1.5:0.5 ratio using Lipofectamine 2000 reagent (Invitrogen) according to the 
manufacturer’s instructions.  Supernatants were harvested 48 h and 72 h after transfection. 
Cells (5 × 105) were mixed in 2 ml viral supernatant supplemented with 8 μg/ml polybrene 
(Millipore), followed by spinfection (60 min, 900 g, 25 °C) and further incubated overnight at 
37°C. For METTL1 knockdown experiments, cells were replated in fresh medium containing 565 
1 μg/ml puromycin and kept in selection medium for 7 days.  For METTL1 rescue experiments, 
GFP+ cells were isolated using a SONY SH800 cell sorter 48 h after infection. 
 
Generation of conditional knockdown cells 
A549 or Caco-2 cells were infected with pLKO-TETon-Puro lentiviral vectors (Addgene Plasmid 570 
#21915) expressing shRNAs against the coding sequence of human METTL1 or a scrambled 
control as described above. The shRNA sequences are listed in Table S8. shRNA was induced 
by treatment with 200 ng/ml doxycycline for the indicated times. 
 
METHOD DETAILS 575 
 
BoRed-Seq and m7G-RIP-Seq 
The detailed protocol of all the procedures required to perform BoRed-Seq and m7G RNA 






stranded smallRNA libraries were prepared using the NEBNext SmallRNA kit (NEB) according 580 
to the manufacturer’s recommendations and sequenced on a HiSeq 4000 (Illumina).  
 
RNA immunoblots and dot blots 
RNA was resolved by denaturing polyacrylamide gel electrophoresis using Novex TBE-urea 
15% precast gels (Thermo Fisher). Equal loading was checked by staining with ethidium 585 
bromide (Sigma-Aldrich), then RNA was transferred to a nylon membrane (Amersham Hybond-
N+, GE Healthcare) by wet electro-blotting in TBE (45 min at 400 mA). 
 
For dot-blot analysis, input RNA or RNA immunoprecipitated with either anti-m7G or isotypic 
non-specific antibodies was spotted onto a nitrocellulose membrane and UV cross-linked at 254 590 
nm (120 mJ/cm2). The membranes were blocked in Denhart’s solution (1% Ficoll, 1% 
polyvinylpyrrolidone, 1% bovine serum albumin; Thermo Fisher) for 1 h at room temperature 
and incubated with m7G antibody for 1 h at room temperature. Signal was detected using HRP 
conjugated secondary antibodies and ECL (GE Healthcare) and developed on a Chemidoc MP 
machine (BioRad). 595 
 
Global gene expression profiling 
Cells were lysed in Qiazol (Qiagen) and total RNA was extracted with miRNeasy mini kit 
(Qiagen). RNA quality was assessed using an Agilent Tapestation RNA; 50 ng of RNA were 
labeled with Low Input QuickAmp Labeling Kit, One-Color (Agilent Technologies), purified and 600 
hybridized overnight onto an Agilent SurePrint G3 Human Gene Expression Array v3 (8x60K) 
before detection according to the manufacturer’s instructions. An Agilent DNA microarray 
scanner (model G2505C) was used for slide acquisition. 
 
RT-qPCR 605 
Cells were lysed in Qiazol (Qiagen) and total RNA was purified using the miRNEasy mini kit 
(Qiagen) according to the manufacturer’s instructions. For mRNA detection, 1 μg of purified total 
RNA was reverse transcribed using the high-capacity cDNA reverse transcription kit (Applied 
Biosystems).  To quantify gene expression, we used probes from Universal ProbeLibrary (UPL; 
Roche) with TaqMan Fast Advanced Master Mix (Thermo Fisher). 610 
 
For specific pri- and pre-miRNA quantification, we size-fractionated large (>200nt, containing 
the pri-miRNAs) and small RNAs (<200nt, containing pre-miRNAs) using RNA Clean & 
Concentrator 5 column kits (Zymo), as per the manufacturer’s instructions. Pri-miRNAs were 
reverse transcribed using the High-Capacity cDNA reverse transcription kit (Applied 615 
Biosystems), which employs random nonamer priming and favors long molecules. Pre-miRNAs 
were reverse transcribed with miScript II RT kit (Qiagen), which is more efficient on short RNAs. 
Primers were designed to anneal either within the stem loop (pre-miRNAs) or to overlap the 
DROSHA cleavage sites (pri-miRNAs). Both pri- and pre-miRNAs were quantified using Fast 
SybrGreen PCR mastermix (Applied Biosystems) according to the manufacturer’s instructions. 620 
 
For mature miRNA detection, total RNA was reverse transcribed and amplified using the 
Taqman Advanced miRNA cDNA Synthesis Kit from Thermo Fisher Scientific. The levels of 






Scientific. All the RT-qPCR experiments were run on an ABI 7900 real-time PCR machine 625 
(Applied Biosystems). GAPDH and RNY1 were used as housekeeping genes for RT-qPCR 
normalization of long and small RNAs, respectively. Primer sequences, UPL probe numbers 
and assay IDs are listed in Table S8. 
 
Western blotting 630 
For total cell protein extraction and Western blot analysis, cells were lysed in a buffer containing 
50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholic acid, 0.1% sodium 
dodecyl sulfate, Complete protease inhibitor cocktail (Roche) and cleared by centrifugation. The 
protein concentration was determined by Bradford assay (Bio-Rad). Proteins were resolved by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose 635 
membrane (Hybond-C Extra, GE Healthcare). Membranes were blocked with 5% milk proteins 
in TBST (50 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.05% Tween-20), and probed with primary 
antibodies overnight. Membranes were then washed three times with TBST (15 min each) and 
probed with a HRP-conjugated secondary anti-rabbit antibody for 1 h. After three more washes, 
signal was detected using HRP conjugated secondary antibodies and ECL (GE Healthcare) and 640 
developed on a BioRad Chemidoc MP machine. 
 
Migration assays 
For transwell migration assays, the lower surface of the transwell inserts (8 μm; Corning) was 
coated with human recombinant fibronectin (1 μg/ml, 1 h at RT; Sigma-Aldrich). A549 cells were 645 
serum-starved overnight and seeded (3×104) in serum-free medium on transwell inserts.  After 7 
h incubation in wells containing DMEM+20% FBS, inserts were stained with crystal violet and 
cells on the lower surface were counted (blindly). 
 
Proliferation assays 650 
4 days after shRNA induction, 105 A549 METTL1 knockdown or Ctrl cells were plated in each 
well of 6-well cell culture plates in normal culture medium. Cells were counted daily for the 
following three days using a Countess II cell counter (Thermo Fisher).  
 
Mature miRNA / hairpin transfection  655 
20 pmol of hsa-let-7e-5p miRNA mimic or control miRNAs (miRIDIAN, Dharmacon) were 
transfected into 2.5 × 105 A549 cells using 2 μl of Lipofectamine 2000 (Thermo Fisher). 10 pmol 
of pri-let-7e hairpins (Integrated DNA Technologies) were transfected into 1.5 × 105 A549 cells 
using the same amount of Lipofectamine as above. 
 660 
Luciferase assay  
A dual luciferase reporter harboring the 3'-UTR of mouse Hmga2 was generated extracting the 
XbaI-NotI digestion fragments from either Hmga2-Luc-wt or Hmga2-Luc-m7 (Mayr et al., 2007; 
Addgene plasmids #14785 and #14788) and subcloning them into pMirGlo (Promega). In order 
to generate stable reporter lines, A549 cells were transfected with the pMirGlo-hmga2(3'-UTR) 665 
constructs. 24 h after transfection, cells were selected using 300 μg/ml G418 for 7 days. 
Subsequently, cells were transfected with 20 pmol of MISSION esiRNAs (Sigma-Aldrich) 






were measured using the Dual-Luciferase Reporter Assay System (Promega) on a CLARIOstar 
microplate reader (BMG Labtech). 670 
 
METTL1 rescue experiments 
cDNA was obtained by reverse transcription of A549 RNA with Superscript III (Thermo Fisher), 
then the METTL1 full-length coding sequence was amplified by PCR and cloned into pHIV-
ZsGreen plasmid (Addgene plasmid #18121) using restriction sites XbaI and NotI. In order to 675 
generate an shRNA-resistant METTL1 sequence, synonymous substitutions were introduced in 
the codons corresponding to shRNA binding sites by long DNA fragment synthesis (GeneArt 
Strings; Thermo Fisher) of the N-terminal portion of METTL1 (up to NheI site). The in vitro 
synthesized fragment was swapped into pHIV-ZsGreen-METTL1 using restriction sites NotI and 
NheI. The same approach was combined to codon mutagenesis to generate the catalytically 680 
inactive METTL1 variant EIR/AAA (amino acids 107-109, that form the SAM-binding pocket of 
the enzyme; see Figure S2I). Primer and long oligonucleotide sequences are listed in Table S8. 
 
METTL1 UV-CLIP 
Adherent cells in a 15 cm dish were rinsed twice in ice-cold PBS, cross-linked at 254 nm (120 685 
mJ/cm2), scraped and lysed on ice for 10 min in 1 ml of fresh lysis buffer (25 mM Tris-HCl pH 
8.0, 150 mM NaCl, 2 mM MgCl2, 0.5% NP-40, 5 mM DTT) supplemented with protease 
inhibitors (Complete tablets, Roche) and RNAse inhibitors (RNaseOUT; Thermo Fisher). 
Lysates were vortexed, then centrifuged at max speed at 4°C for 5 min. The supernatants were 
used in immunoprecipitation (IP) assay with 5 μg of anti METTL1-antibody (sheep polyclonal 690 
obtained by MRC Protein Phosphorylation Unit, #588192; Cartlidge et al., 2005) or control 
isotypic IgG at 4 °C for 90 min, with rotation. 80 μl of Protein G Dynabeads (Invitrogen) per IP 
reaction were rinsed 2 times with lysis buffer and blocked with 1 mg/ml BSA (NEB) for 2 h at 4 
°C. Beads were resuspended in 100 μl lysis buffer, then added to the IP tube. The reaction was 
incubated at 4 °C for 2 h with rotation. Beads were then washed twice with high-salt buffer (25 695 
mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM MgCl2, 1% NP-40, 5 mM DTT) and three times with 
lysis buffer. Immunoprecipitated samples were treated with DNAse I (Qiagen) followed by 
digestion with Proteinase K (NEB). RNA was purified using an RNeasy MinElute column kit 
(Qiagen).   
 700 
Expression and purification of recombinant METTL1/WDR4 (Evotec) 
The constructs EV4866 (his-METTL1) and EV4868 (flag-WDR4) were cloned into plasmid 
pTriIJ-HV (Evotec). Recombinant virus was produced by co-transfecting transfer plasmid DNA 
and bacmid DNA in insect cells.  100 ng bacmid DNA and 500 ng transfer plasmid DNA were 
mixed with 2 µl Cellfectin II transfection reagent (Invitrogen) in 200 µl TC100 media (Sigma) and 705 
incubated at room temperature for 2-3 h. Sf21 insect cells, grown to 80-90% confluency in 24 
well plates were washed with TC100 before adding 0.2 ml TC100 and 0.2 ml co-transfection 
mix. After overnight incubation, 0.6 ml Sf900 II SFM media containing 5 µg/ml gentamicin was 
added and the cells were incubated at 27 °C for six days with humidity. The cells were observed 
under an inverted microscope and compared to the mock-transfected control. BluoGal (2%) was 710 
added to the LacZ positive control well and blue coloration was observed within 1 h. Following 






harvested into a sterile deep well block and stored in the dark at 4 °C. P1 BIICs (baculovirus-
infected insect cells) were amplified in a sterile 24-deep well block by infecting Sf21 cells grown 
in Sf900 II SFM media containing 5 µg/ml gentamicin with P0 virus. The infected cultures were 715 
incubated for 72-120 h at 27 °C with shaking at 360 rpm. P1-BIICs were harvested by 
centrifugation of the block and virus supernatant was removed to a fresh block and stored at 4 
°C. The cells were then re-suspended in freezing mix (Sf900 II + 10% heat inactivated FBS + 
10% DMSO) and frozen gradually to -80 °C, in the block. Working P2-BIICs were amplified by 
infecting Sf21 cells grown in shake flasks at MOI-0.1 using P1-BIICs and incubated for 72 h. P2-720 
BIICs were harvested by centrifugation and infected cells were resuspended in freezing media 
and stored at -80 °C. Sf21 cells grown in Sf900 II SFM media plus 5 µg/ml gentamicin were 
infected with both EV4866 and EV4868 P2 BIICs at an MOI of 2 (1+1). The infected culture was 
incubated for 72 h at 27 °C with shaking at 110 rpm, before harvesting by centrifugation and 
storing at -80 °C. Thawed cells were lysed in 25 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM 725 
TCEP, 5% glycerol, 0.25% CHAPS supplemented with Complete EDTA-free protease inhibitor 
tablets (Roche). Samples were homogenised for 20-30 sec with an IKA Ultra-Turrax and 
sonicated in a Branson probe sonicator (cycles of 30 sec on, 30 sec off for 5 minutes at 40% 
amplitude). Samples were centrifuged at 45000 rpm for 50 min to remove insoluble material. 
Purification was carried out by sequential Ni-affinity and size-exclusion chromatography on an 730 
ÄKTA Xpress system (GE). Samples were bound to 1 ml HisTrap FF column, washed with 25 
mM Tris-HCl pH 8.0, 300 mM NaCl, 1mM TCEP, 5% glycerol, 20 mM imidazole and eluted with 
a step elution over 20 CV of 25 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM TCEP, 5% glycerol 
and 500 mM imidazole at a flow rate of 0.8 ml/min. This was followed by size-exclusion on a 
16/60 S200 column (25 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM TCEP, 5% glycerol) at a flow 735 
rate of 1 ml/min. Purified protein was analyzed by SDS-PAGE, western blotting and 
measurement of A260/A280 to estimate levels of contaminating nucleosides. Aliquoted protein 
was snap-frozen in liquid nitrogen and stored at -80 °C. 
 
In vitro RNA methylation assays 740 
Recombinant METTL1/WDR4 (300 nM; Evotec) was incubated for 2 hours with S-
adenosylmethionine (15 µM) and oligonucleotide (1 µM) in a Tris-HCl pH 8.0 buffer (20 mM) 
supplemented with 1 mM DTT and 0.01% Triton X-100.  
 
Mass spectrometry analysis of RNA nucleoside m7G modification 745 
Nucleosides were prepared from enzyme-processed RNA by enzymatic digestion, using a 
cocktail of Benzonase (Merck), Phosphodiesterase 1 (Merck), and Antarctic Phosphatase (New 
England Biolabs) as described previously (van Delft et al., 2017).  The reactions were filtered 
using an Amicon 30kDa MWCO spin-column (Merck) to remove protein and the filtrate was 
mixed with a 2x loading buffer containing 0.1% formic acid and an internal standard (13C-750 
labelled uridine generated from 645672-1MG Merck KGaA, previously treated with Antarctic 
Phosphatase). The samples were loaded onto an ACQUITY UPLC HSS T3 Column, 100 Å, 1.8 
µm, 1 mm X 100 mm (Waters Corp., Milford, MA, USA) and resolved using a gradient of 2-10% 
acetonitrile in 0.1% formic acid over ten minutes.  Mass spectrometric analysis was performed 
in positive ion mode on an Orbitrap QExactive HF (Thermo Fisher, Waltham, MA, USA) mass 755 






in parallel.  There were three technical replicates of each sample and the analytical processing 
was performed using XCalibur Software (Thermo Fisher). 
 
Mature miRNA isolation 760 
Mature miRNA fraction was isolated from total RNA by gel extraction: RNA was denatured by 
incubation at 73 °C for 3 min in 2X Urea Sample Buffer (Thermo Fisher) and run in a 10% TBE–
urea precast polyacrylamide gel (Thermo Fisher) at 250V for 12 min. Gel was visualized by 
ethidium bromide staining and the region corresponding to the expected size of mature miRNAs 
was excised using a synthetic 20-nt RNA ruler. After breaking the gel, miRNAs were eluted in a 765 
sodium acetate buffer (0.3 M sodium acetate, pH 5.2, 5 mM EDTA, 0.1% sodium 
dodecylsulfate) by freeze-thawing once on dry ice and incubating at 4°C overnight. miRNAs 
were purified by ethanol precipitation.  
 
Context-specific mass spectrometry analysis of miRNA m7G modification 770 
Oligonucleotides were prepared from miRNA fraction using RNAse A (Thermo Fisher) and 
chromatographically separated by ion pair reverse phase chromatography (200 mM 
Hexafluoroisopropanol [HFIP], 8.5 mM triethylamine [TEA] in water as eluent A, and 100 mM 
HFIP, 4.25 mM TEA in methanol as eluent B). The oligonucleotides were resolved by a gradient 
of 2.5% to 20% B at 200 nl/min on Acclaim™ PepMap™ C18 solid phase (Thermo Fisher) and 775 
characterised by negative ion tandem LC-MS in a hybrid quadrupole – orbitrap (QExactive HF, 
Thermo Fisher). Data were collected in data-dependent acquisition mode in pathfinding 
experiments before subsequent hybrid acquisition investigation. Full scan MS1 data was 
acquired between 700 and 3500 m/z and extracted ion chromatograms from these data were 
used for label-free quantification of oligonucleotides derived from let-7. MS2 data were collected 780 
in subsequent scan events for the same let-7 oligonucleotides by targeted, multiplexed, data-
independent acquisition on filtered precursor ion masses multiplexed from the double and triple 
charge states of unmodified and monomethylated AGGAGGU (m/z of 1180.158, 786.436, 
1187.166 and 791.108, with a window of 3 m/z). Technical replicates of n=3 were acquired, with 
MS2 ions matched with to within 5 ppm. 785 
 
Preparation of naive and in vitro methylated [α-32P]-pri-let-7e 
Plasmid pcDNA3-pri-let-7e (Addgene #51380; Heo et al., 2008) linearized by digestion with 
XbaI (NEB) was used as a template for RNA in vitro transcription in the presence of [α-32P]-GTP 
(Perkin Elmer) using TranscriptAid T7 High Yield Kit (Thermo Fisher). The resulting RNA 790 
(369bp) was denatured by incubation at 73 °C for 3 min in 2X Urea Sample Buffer (Thermo 
Fisher) and run in a 6% TBE–urea precast polyacrylamide gel (Thermo Fisher). The band 
corresponding to the expected size of pri-let-7e transcript was excised using autoradiography 
and, after breaking the gel, RNA was eluted as described above for mature miRNA isolation. 
 795 
2.5 μg of 32P-labeled pri-let-7e (1 μM) were incubated for 3 hours at 37°C in the presence of 
recombinant METTL1/WDR4 (300 nM) and S-adenosylmethionine (1 mM) in a methylation 
buffer (85 mM Tris-HCl pH 8.0, 1.4 mM DTT, 0.07 mM EDTA, 1 mM spermidine). Methylated 
pri-let-7e was isolated by immunoprecipitation using m7G-specific antibody, purified on RNA 







Isolation of DROSHA by IP 
Immunopurification of DROSHA and in vitro processing assays were performed according to a 
published protocol (Lee et al., 2002). HEK-293T cells transfected with pcDNA4/TO/cmycDrosha 
plasmid (Landthaler et al., 2004; Addgene plasmid #10828) were lysed after 48h in buffer D (20 805 
mM HEPES–KOH pH 7.9, 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, 5% 
glycerol) by sonication (Bioruptor: 5 min; 30 sec ON / 30 sec OFF, 200W) followed by 
centrifugation. 2 mg of crude extract were incubated with 12 μg of anti-myc-tag antibody 
(Abcam) for 2 h at 4°C, then the recombinant enzyme was pulled-down with 30 μl Protein G 
Sepharose 4 Fast Flow beads (GE Healthcare) and washed 4 times in buffer D. Whole‐ cell 810 
extracts were prepared from control and METTL1 knockdown A549 cells using the same lysis 
protocol as above. 
 
In vitro miRNA Processing Assays 
For comparing the pri- to pre-miRNA processing efficiency by DROSHA, 30000 cpm (50-100 815 
ng) of either naive or in vitro methylated pri-let-7e were incubated with 15 μl of DROSHA-IP 
beads, 6.4 mM MgCl2 and 1U/μl RNAseOUT RNAse inhibitor (ThermoFisher) for 80 min at 
37°C. 
 
For evaluating the processing activity of METTL1 depleted cells, 10 μl of processing reaction 820 
containing 5 μl of whole-cell extract, 1 μl of solution A (32 mM MgCl2, 5 mM ATP, 200 mM 
creatine phosphate), 1 μl 32 mM S-adenosyl methionine, 1 U/μl RNase inhibitor (Thermo 
Fisher) and the labeled transcripts (104-105 c.p.m.) were incubated at 37 °C for 120 min. 
 
All processing reactions were purified with RNA Clean & Concentrator - 5 column kit (Zymo), 825 
measured and equalized by scintillation counting, resolved on a 6% TBE–urea precast 
polyacrylamide gel (Thermo Fisher) and developed by autoradiography exposing the dried gel 
on Amersham Hyperfilm high-sensitivity film (GE Healthcare).  
 
Circular dichroism spectroscopy 830 
CD experiments were conducted on a Chirascan Plus spectropolarimeter. Oligonucleotide 
solutions were prepared at a final concentration of 10 µM (rG4-let-7e oligonucleotides) or 2.5 
µM (let-7e hairpins) in 10 mM lithium cacodylate (pH 7.2) containing 1mM EDTA and 
supplemented with 100 mM of LiCl, NaCl or KCl. Oligonucleotides were annealed by heating at 
95 °C for 3 min and cooling the solutions at 4 °C for 4 h. Scans were performed over the range 835 
of 200–320 nm at 5 °C. Each trace was the result of the average of three scans taken with a 
step size of 1 nm, a time per point of 1 s and a bandwidth of 1 nm. A blank sample containing 
only buffer was treated in the same manner and subtracted from the collected data. The data 
were finally baseline corrected at 320 nm. Denaturation experiments were performed by heating 
the samples to 95 °C using the stepped temperature ramping mode, a setting time of 10 s and 840 
with data collection every 1 °C monitoring the CD signal at 263 and 210 nm. Differential melting 
curves (quantification of folded fractions) were obtained by subtracting the upper baseline to the 
signal and dividing by the difference between the upper and lower baseline. Melting 
temperatures (T1/2) values were extracted as the local minima of the first derivatives of a 








Control or METTL1 knockdown cells (n=2) were treated 5 days after doxycycline induction with 
0.1 mg/ml cycloheximide for 5 min at 37°C, then they were lysed and polysomes were 
fractionated on a sucrose gradient while measuring absorbance at 254 nm (Panda et al., 2017). 850 
 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
 
Bioinformatic analysis of smallRNA sequencing 855 
Multiplexed reads were split on the basis of their barcodes using Illumina Basespace. Read 
quality was assessed using FastQC program (https://github.com/s-andrews/FastQC). Library 
adaptors were trimmed with Trimmomatic (Bolger et al., 2014), and reads were mapped to the 
human genome (NCBI GRCh38/hg38) with STAR (Dobin et al., 2013), using the parameters of 
ENCODE guidelines: --runThreadN 15 --sjdbGTFfile /path/to/GENCODE_miRNA_subset.gtf --860 
alignEndsType EndToEnd --outFilterMismatchNmax 1 --outFilterMultimapScoreRange 0 --
outSAMtype BAM SortedByCoordinate --outFilterMultimapNmax 10 --outSAMunmapped Within 
--outFilterScoreMinOverLread 0 --outFilterMatchNminOverLread 0 --outFilterMatchNmin 16 --
alignSJDBoverhangMin 1000 --alignIntronMax 1 (Davis et al., 2018). Reads were summarized 
using featureCounts (Liao et al., 2014) according to miRbase22 annotation (Kozomara and 865 
Griffiths-Jones, 2014) of mature miRNAs. Differential miRNA enrichment in either m7G-RIP or 
BoRed-Pulldown over input/control sample was evaluated through negative binomial Wald test 
with the R package DESeq2 (Love et al., 2014; n=2 for BoRed-Seq; n=5 for m7G-RIP-Seq 
experiments). 
 870 
Global gene expression analysis 
Microarray spot analysis was performed with Feature Extraction software (Agilent 
Technologies). Data were background-corrected and quantile normalized among arrays using 
the Bioconductor package limma (Smyth and Speed, 2003; Smyth et al., 2005). The statistical 
significance of differential gene expression was calculated with the empirical Bayes method 875 
implemented in limma. KEGG pathway ontologies over-represented in the subset of genes up-
regulated or down-regulated upon METTL1 knockdown were evaluated using the R package 
Gage (Luo et al., 2009, 2017). 
 
In order to identify the mRNAs that are predicted to be targets of selected miRNAs, we 880 
extracted the positive hits of at least 3 out of 6 in silico prediction algorithms (namely miRWalk, 
miRanda, miRDB, Pictar2, RNA22 and Targetscan) using miRWalk 2.0 web server (Dweep and 
Gretz, 2015). 
 
For unbiased analysis of miRNA seed sequences enriched in the top upregulated genes upon 885 
METTL1 knockdown, we took advantage of the Sylamer online software (van Dongen et al., 
2008). 
 
To produce a classification model predicting mRNA upregulation upon METTL1 knockdown, we 
extracted the subset of genes expressed above the background (log2 Average expression > 6). 890 






then a model employing the presence of putative miRNA target sites as predictors was 
generated by gradient boosting using R package gbm (Freund and Schapire, 1997). 
 
Bioinformatic prediction of G-quadruplexes 895 
Stem-loop and mature miRNA sequences were recovered from miRBase (Kozomara and 
Griffiths-Jones, 2014) release 22. These sequences were used to calculate the quantitative 
parameters used to describe the different miRNA features discussed in this manuscript. Base 
composition was assessed using a custom Python script. G-score, a quantitative estimation of 
G-richness and G-skewness, is based on the G4Hunter algorithm (Bedrat et al., 2016). Briefly, 900 
each position in a sequence is given a score between -4 and 4. To account for G-richness, a 
single G is given a score of 1, in a GG sequence each G is given a score of 2; in a GGG 
sequence each G is given a score of 3; and in a sequence of 4 or more Gs each G is given a 
score of 4. To account for G-skewness, Cs are scored similarly but their values are negative. 
The Gscore is the maximum value obtained while scanning miRNA sequences using a 20nt 905 
window and averaging the score of each nucleotide over the considered window. 
 
G-quadruplex forming motifs, G2N7, G2N3, G3N7 and G3N12 are sequences of the form 
G2+N1–7G2+N1–7G2+N1–7G2+, G2+N1–3G2+N1–3G2+N1–3G2+, G3+N1–7G3+N1–7G3+N1–7G3+ and G3+N1–
12G3+N1–12G3+N1–12G3+ respectively, where N is any base. G3N7 represents the strict definition of 910 
G4 forming sequences according to the Quadparser algorithm (Huppert and Balasubramanian, 
2005). Other motifs represent the loose definition of G4 forming sequences (Kwok et al. 2016a). 
The presence of each motif within miRNA sequences was assessed using the re.finditer 
function in custom python scripts. 
 915 
RNA secondary structures were predicted using the RNAfold 2.2.10 algorithm of the 
ViennaRNA package (Lorenz et al. 2011). RNAfold computes the minimum free energy (MFE) 
of optimal secondary structures via estimation of base pairing probabilities. MFEs of dsRNA 
secondary structures (ΔG0dsRNA) were computed at 37 °C. MFEs of G4 secondary structures 
(ΔG0G4) were computed by subtracting MFEs obtained when considering G4 formation into the 920 
structure prediction algorithm to the previous values (ΔG0G4 = ΔG0dsRNA - ΔG0(dsRNA + G4)). RNAfold 
was used to assess the stability of predicted RNA structures within miRNA sequences using a 
20nt sliding window. m7G-containing miRNAs are the subset of miRNAs that have been 
enriched from the total population of miRNAs using both the BoRed-Seq and m7G-RIP-Seq 
protocols. Background is the rest of annotated miRNAs. For assessing the local enrichment of 925 
structures within m7G-containing precursor miRNAs, pre-miRNA sequences were piled up and 
centered, MFE values were then averaged at each position. Data were compiled and plotted 
using R. 
 
Statistical analysis 930 
All general statistical analyses were performed using either a two-tailed Student’s t-test or a 
Wilcoxon test (when distributions were assessed not to be normal and homoscedastic) at a 
confidence interval of 95%, unless otherwise specified. No statistical methods were used to 








DATA AND SOFTWARE AVAILABILITY  
 
Data Resource 
Raw genomic data have been deposited in the Gene Expression Omnibus database with 
accession number GSE112182 (Expression Microarray data: GSE112180; BoRed-seq and 
m7G-RIP-seq in A549: GSE112181; m7G-RIP-Seq in Caco-2: GSE120454; m7G-RIP-Seq in 940 
A549 METTL1 knockdown: GSE120455). Unprocessed imaging data are deposited on 
Mendeley Data: (http://dx.doi.org/10.17632/yscng45zgj.1). All other data and analysis scripts 









































Supplemental Material titles and legends 
 
Table S1 | BoRed-Seq miRNA enrichment. Related to Figure 1. 
Excel table containing log2 enrichment, average expression, P-values and FDR of miRNAs, as 
obtained by BoRed-Seq. 
 
Table S2 | m7G-RIP-Seq miRNA enrichment in A549 cells. Related to Figure 1. 
Excel table containing log2 enrichment, average expression, P-values and FDR of miRNAs, as 
obtained by m7G-RIP-Seq in A549 cells. 
 
Table S3 | m7G-harboring miRNAs. Related to Table 1. 
Excel table containing a list of m7G-harboring miRNAs that are significantly enriched in both 
BoRed-Seq and m7G-RIP-Seq in A549 cells. 
 
Table S4 | m7G-RIP-Seq miRNA enrichment in Caco-2 cells.  Related to Figure 1. 
Excel table containing a list of m7G-harboring miRNAs that are significantly enriched in both 
BoRed-Seq and m7G-RIP-Seq in Caco-2 cells. 
Table S5 | miRNA modulation upon METTL1 knockdown. Related to Figure 1. 
Excel table containing log2 fold change, average expression, P-values and FDR of miRNAs, as 
obtained by small RNA-Seq in WT and METTL1 knockdown A549 cells. 
Table S6 | Gene expression changes upon METTL1 knockdown. Related to Figure 2. 
Excel table containing log2 fold change, average expression, P-values and FDR of mRNAs, as 
obtained by gene expression microarrays of WT and METTL1 knockdown A549 cells. 
Table S7 | Gene ontologies affected by METTL1 knockdown. Related to Figure 2. 






























Alarcón, C.R., Lee, H., Goodarzi, H., Halberg, N., and Tavazoie, S.F. (2015). N6-
methyladenosine marks primary microRNAs for processing. Nature 519, 482–485. 
Alexandrov, A., Martzen, M.R., and Phizicky, E.M. (2002). Two proteins that form a complex are 
required for 7-methylguanosine modification of yeast tRNA. RNA 8, 1253–1266. 
Balzeau, J., Menezes, M.R., Cao, S., and Hagan, J.P. (2017). The LIN28/let-7 Pathway in 
Cancer. Front. Genet. 8, 31. 
Bao, X., Guo, X., Yin, M., Tariq, M., Lai, Y., Kanwal, S., Zhou, J., Li, N., Lv, Y., Pulido-Quetglas, 
C., et al. (2018). Capturing the interactome of newly transcribed RNA. Nat. Methods 15, 213–
220. 
Bartel, D.P. (2009). MicroRNAs: Target Recognition and Regulatory Functions. Cell 136, 215–
233. 
Bartel, D.P. (2018). Metazoan MicroRNAs. Cell 173, 20–51. 
Bedrat, A., Lacroix, L., and Mergny, J.-L. (2016). Re-evaluation of G-quadruplex propensity with 
G4Hunter. Nucleic Acids Res. 44, 1746–1759. 
Bolger, a. M., Lohse, M., and Usadel, B. (2014). Trimmomatic: A flexible read trimming tool for 
Illumina NGS data. Bioinformatics 30, 2114–2120. 
Bugaut, A., and Balasubramanian, S. (2012). 5’-UTR RNA G-quadruplexes: translation 
regulation and targeting. Nucleic Acids Res. 40, 4727–4741. 
Carell, T., Brandmayr, C., Hienzsch, A., Müller, M., Pearson, D., Reiter, V., Thoma, I., Thumbs, 
P., and Wagner, M. (2012). Structure and Function of Noncanonical Nucleobases. Angew. 
Chemie Int. Ed. 51, 7110–7131. 
Carlile, T.M., Rojas-Duran, M.F., Zinshteyn, B., Shin, H., Bartoli, K.M., and Gilbert, W. V. (2014). 
Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. 
Nature 515, 143–146. 
Cartlidge, R.A., Knebel, A., Peggie, M., Alexandrov, A., Phizicky, E.M., and Cohen, P. (2005). 
The tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and 
in cells. EMBO J. 24, 1696–1705. 
Chakraborty, C., Sharma, A.R., Sharma, G., Doss, C.G.P., and Lee, S.-S. (2017). Therapeutic 
miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine. Mol. Ther. 






Chendrimada, T.P., Gregory, R.I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., and 
Shiekhattar, R. (2005). TRBP recruits the Dicer complex to Ago2 for microRNA processing and 
gene silencing. Nature 436, 740–744. 
Dai, Q., Moshitch-Moshkovitz, S., Han, D., Kol, N., Amariglio, N., Rechavi, G., Dominissini, D., 
and He, C. (2017). Nm-seq maps 2′-O-methylation sites in human mRNA with base precision. 
Nat. Methods 14, 695–698. 
Davis, C.A., Hitz, B.C., Sloan, C.A., Chan, E.T., Davidson, J.M., Gabdank, I., Hilton, J.A., Jain, 
K., Baymuradov, U.K., Narayanan, A.K., et al. (2018). The Encyclopedia of DNA elements 
(ENCODE): data portal update. Nucleic Acids Res. 46, D794–D801.
Delatte, B., Wang, F., Ngoc, L. V., Collignon, E., Bonvin, E., Deplus, R., Calonne, E., Hassabi, 
B., Putmans, P., Awe, S., et al. (2016). Transcriptome-wide distribution and function of RNA 
hydroxymethylcytosine. Science 351, 282–285. 
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, 
M., and Gingeras, T.R. (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 
15–21. 
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., 
Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012). Topology 
of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201–206. 
Dominissini, D., Nachtergaele, S., Moshitch-Moshkovitz, S., Peer, E., Kol, N., Ben-Haim, M.S., 
Dai, Q., Di Segni, A., Salmon-Divon, M., Clark, W.C., et al. (2016). The dynamic N(1)-
methyladenosine methylome in eukaryotic messenger RNA. Nature 530, 441–446. 
van Dongen, S., Abreu-Goodger, C., and Enright, A.J. (2008). Detecting microRNA binding and 
siRNA off-target effects from expression data. Nat. Methods 5, 1023–1025. 
Dweep, H., and Gretz, N. (2015). miRWalk2.0: a comprehensive atlas of microRNA-target 
interactions. Nat. Methods 12, 697–697. 
Endoh, T., Kawasaki, Y., and Sugimoto, N. (2013). Translational halt during elongation caused 
by G-quadruplex formed by mRNA. Methods 64, 73–78. 
Fabian, M.R., Sonenberg, N., and Filipowicz, W. (2010). Regulation of mRNA Translation and 
Stability by microRNAs. Annu. Rev. Biochem. 79, 351–379. 
Freund, Y., and Schapire, R.E. (1997). A Decision-Theoretic Generalization of On-Line Learning 
and an Application to Boosting. J. Comput. Syst. Sci. 55, 119–139. 
Ghildiyal, M., and Zamore, P.D. (2009). Small silencing RNAs: an expanding universe. Nat. 
Rev. Genet. 10, 94–108. 
Heo, I., Joo, C., Cho, J., Ha, M., Han, J., and Kim, V.N. (2008). Lin28 Mediates the Terminal 






Huppert, J.L., and Balasubramanian, S. (2005). Prevalence of quadruplexes in the human 
genome. Nucleic Acids Res. 33, 2908–2916. 
Irie, H.Y., Pearline, R. V., Grueneberg, D., Hsia, M., Ravichandran, P., Kothari, N., Natesan, S., 
and Brugge, J.S. (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and 
epithelial–mesenchymal transition. J. Cell Biol. 171, 1023–1034. 
Kozomara, A., and Griffiths-Jones, S. (2014). MiRBase: Annotating high confidence microRNAs 
using deep sequencing data. Nucleic Acids Res. 42, D68-73. 
Kriek, E., and Emmelot, P. (1964). Methylation of deoxyribonucleic acid by diazomethane. 
Biochim. Biophys. Acta 91, 59–66. 
Kwok, C.K., Marsico, G., Sahakyan, A.B., Chambers, V.S., and Balasubramanian, S. (2016a). 
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome. 
Nat. Methods 13, 841–844. 
Kwok, C.K., Sahakyan, A.B., and Balasubramanian, S. (2016b). Structural Analysis using 
SHALiPE to Reveal RNA G-Quadruplex Formation in Human Precursor MicroRNA. Angew. 
Chemie Int. Ed. 55, 8958–8961. 
Kypr, J., Kejnovská, I., Renciuk, D., and Vorlícková, M. (2009). Circular dichroism and 
conformational polymorphism of DNA. Nucleic Acids Res. 37, 1713–1725. 
Landthaler, M., Yalcin, A., and Tuschl, T. (2004). The Human DiGeorge Syndrome Critical 
Region Gene 8 and Its D. melanogaster Homolog Are Required for miRNA Biogenesis. Curr. 
Biol. 14, 2162–2167. 
Langmead, B., and Salzberg, S.L. (2012). Fast gapped-read alignment with Bowtie 2. Nat. 
Methods 9, 357–359. 
Lee, Y.S., and Dutta, A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 
oncogene. Genes Dev. 21, 1025–1030. 
Lee, Y., Jeon, K., Lee, J.-T., Kim, S., and Kim, V.N. (2002). MicroRNA maturation: stepwise 
processing and subcellular localization. EMBO J. 21, 4663–4670. 
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., 
et al. (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–
419. 
Lehmann, S.M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., 
Eom, G., Hinz, M., Kaul, D., et al. (2012). An unconventional role for miRNA: let-7 activates Toll-
like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15, 827–835. 
Liao, Y., Smyth, G.K., and Shi, W. (2014). featureCounts: an efficient general purpose program 






Lin, S., Liu, Q., Lelyveld, V.S., Choe, J., Szostak, J.W., and Gregory, R.I. (2018). Mettl1/Wdr4-
Mediated m7G tRNA Methylome Is Required for Normal mRNA Translation and Embryonic 
Stem Cell Self-Renewal and Differentiation. Mol. Cell 71, 244–255.e5.  
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and 
dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. 
Luo, W., Friedman, M.S., Shedden, K., Hankenson, K.D., and Woolf, P.J. (2009). GAGE: 
generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10, 161. 
Luo, W., Pant, G., Bhavnasi, Y.K., Blanchard, S.G., and Brouwer, C. (2017). Pathview Web: 
user friendly pathway visualization and data integration. Nucleic Acids Res. 45, W501–W508. 
Machnicka, M.A., Milanowska, K., Osman Oglou, O., Purta, E., Kurkowska, M., Olchowik, A., 
Januszewski, W., Kalinowski, S., Dunin-Horkawicz, S., Rother, K.M., et al. (2013). MODOMICS: 
a database of RNA modification pathways--2013 update. Nucleic Acids Res. 41, D262-7. 
Mayr, C., Hemann, M.T., and Bartel, D.P. (2007). Disrupting the Pairing Between let-7 and 
Hmga2 Enhances Oncogenic Transformation. Science 315, 1576–1579. 
McDaniel, K., Hall, C., Sato, K., Lairmore, T., Marzioni, M., Glaser, S., Meng, F., and Alpini, G. 
(2016). Lin28 and let-7: roles and regulation in liver diseases. Am. J. Physiol. Gastrointest. Liver 
Physiol. 310, G757-65. 
Mergny, J.L., Phan, A.T., and Lacroix, L. (1998). Following G-quartet formation by UV-
spectroscopy. FEBS Lett. 435, 74–78. 
Mirihana Arachchilage, G., Dassanayake, A.C., and Basu, S. (2015). A potassium ion-
dependent RNA structural switch regulates human pre-miRNA 92b maturation. Chem. Biol. 22, 
262–272. 
Panda, A.C., Martindale, J.L., and Gorospe, M. (2017). Polysome Fractionation to Analyze 
mRNA Distribution Profiles. Bio-Protocol 7. 
Pandey, S., Agarwala, P., Jayaraj, G.G., Gargallo, R., and Maiti, S. (2015). The RNA Stem–
Loop to G-Quadruplex Equilibrium Controls Mature MicroRNA Production inside the Cell. 
Biochemistry 54, 7067–7078. 
Peattie, D.A. (1979). Direct chemical method for sequencing RNA. Proc. Natl. Acad. Sci. U. S. 
A. 76, 1760–1764. 
Piekna-Przybylska, D., Decatur, W.A., and Fournier, M.J. (2007). The 3D rRNA modification 
maps database: with interactive tools for ribosome analysis. Nucleic Acids Res. 36, D178–
D183. 
Rommler, F., Jurk, M., Uhlmann, E., Hammel, M., Waldhuber, A., Pfeiffer, L., Wagner, H., 
Vollmer, J., and Miethke, T. (2013). Guanine Modification of Inhibitory Oligonucleotides 






Roundtree, I.A., Evans, M.E., Pan, T., and He, C. (2017). Dynamic RNA Modifications in Gene 
Expression Regulation. Cell 169, 1187–1200. 
Schaefer, M. (2015). RNA 5-Methylcytosine Analysis by Bisulfite Sequencing. In Methods in 
Enzymology, pp. 297–329. 
Schwartz, S., Bernstein, D.A., Mumbach, M.R., Jovanovic, M., Herbst, R.H., León-Ricardo, B.X., 
Engreitz, J.M., Guttman, M., Satija, R., Lander, E.S., et al. (2014). Transcriptome-wide Mapping 
Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNA. Cell 159, 
148–162. 
Shyh-Chang, N., Zhu, H., Yvanka de Soysa, T., Shinoda, G., Seligson, M.T., Tsanov, K.M., 
Nguyen, L., Asara, J.M., Cantley, L.C., and Daley, G.Q. (2013). Lin28 Enhances Tissue Repair 
by Reprogramming Cellular Metabolism. Cell 155, 778–792. 
Smyth, G.K., and Speed, T. (2003). Normalization of cDNA microarray data. Methods 31, 265–
273. 
Smyth, G.K., Michaud, J., and Scott, H.S. (2005). Use of within-array replicate spots for 
assessing differential expression in microarray experiments. Bioinformatics 21, 2067–2075. 
Tanaka, M., Han, S., Song, H., Küpfer, P.A., Leumann, C.J., and Sonntag, W.E. (2011). An 
assay for RNA oxidation induced abasic sites using the Aldehyde Reactive Probe. Free Radic. 
Res. 45, 237–247. 
van Delft, P., Akay, A., Huber, S.M., Bueschl, C., Rudolph, K.L.M., Di Domenico, T., 
Schuhmacher, R., Miska, E.A., and Balasubramanian, S. (2017). The Profile and Dynamics of 
RNA Modifications in Animals. ChemBioChem 18, 979–984. 
Xhemalce, B., Robson, S.C., and Kouzarides, T. (2012). Human RNA Methyltransferase 
BCDIN3D Regulates MicroRNA Processing. Cell 151, 278–288. 
Zhang, H., Hao, Y., Yang, J., Zhou, Y., Li, J., Yin, S., Sun, C., Ma, M., Huang, Y., and Xi, J.J. 
(2011). Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing 
cancer metastasis. Nat. Commun. 2, 554. 
Zueva, V.S., Mankin, A.S., Bogdanov, A.A., and Baratova, L.A. (1985). Specific fragmentation of 
tRNA and rRNA at a 7-methylguanine residue in the presence of methylated carrier RNA. Eur. 
J. Biochem. 146, 679–687. 
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Anti-m7G Mouse Monoclonal MBL (RN017M) RRID: 
AB_2725740 
Anti-METTL1 Rabbit Polyclonal Abcam (ab157097) RRID: 
AB_2725741 
Anti-METTL1 Sheep Polyclonal (for IP) MRC PPU (588192) RRID: 
AB_2725742 
Anti-HMGA2 Rabbit Polyclonal Abcam (ab202387) RRID: 
AB_2725743 
Anti β-Tubulin Rabbit Polyclonal Abcam (ab6046) RRID: 
AB_2210370 
IgG Rabbit Isotype Control  Abcam (ab171870) RRID: 
AB_2687657 
Anti-FLAG tag Mouse Monoclonal Sigma-Aldrich (F1804) RRID: AB_262044 
Anti-6xHIS tag Rabbit Polyclonal Abcam (ab9108) RRID: AB_307016 
Anti-Myc tag Mouse Monoclonal Abcam (ab32) RRID: AB_303599 
Anti-Rabbit IgG HRP-conjugated Goat Polyclonal Abcam (ab6721) RRID: AB_955447 
Anti-Mouse IgG HRP-conjugated Goat Polyclonal Dako (P0447) RRID: 
AB_2617137 
Bacterial and Virus Strains  
TOP10 Chemically Competent E. coli Thermo Fisher Cat# C404003 
Chemicals, Peptides, and Recombinant Proteins 
1,1,1,3,3,3-Hexafluoropropan-2-ol Apollo Scientific Cat# PC0877 
1,4-Dithiothreitol Thermo Fisher Cat# P2325 
2-Mercaptoethanol Sigma-Aldrich Cat# M3148 
7-methylguanosine triphosphate Sigma-Aldrich Cat# M6133 
Acetic Acid Fisher Scientific Cat# A/0400/PB17 
Acetonitrile Fisher Scientific Cat# 10407440 
Antarctic Phosphatase NEB Cat# M0289S 
Adenosine 5'-Triphosphate NEB Cat# P0756S 
Benzonase Sigma-Aldrich Cat# E1014-25KU 
Boric Acid BDH Lab. Supplies Cat# 100584S 
Bovine Serum Albumin NEB Cat# B9000S 
Cacodylic acid Sigma-Aldrich Cat# C0125 
CapCLIP Acid Pyrophosphatase CellScript Cat# C-CC15011H 
Chloroform Fisher Scientific Cat# C/4960/15 
Cycloheximide Sigma-Aldrich Cat# C7698   
Deoxycholic acid Sigma-Aldrich Cat# D2510  
DNAse I Qiagen Cat# 79254 
Doxycycline Clontech Cat# 8634-1 
Ethylenediaminetetraacetic Acid Fisher Scientific Cat# D/0700/53 
Ethanol VWR Cat# 20820.327 
Ethidium Bromide Sigma-Aldrich Cat# E1510 
Fibronectin Sigma-Aldrich Cat# F2006 
Formaldehyde 37% Sigma-Aldrich Cat# 252549 
Formic acid Fisher Scientific Cat# 10596814 
G418 disulphate Melford Cat# G0175 
Glycogen Roche Cat# 
10901393001 
Key Resource Table
HEPES Melford Cat# B2001 
KCl Sigma-Aldrich Cat# P9333 
LiCl Sigma-Aldrich Cat# L-4408 
Lipofectamine 2000 Thermo Fisher Cat# 11668019 
Lithium Hydroxide Sigma-Aldrich Cat# 442410 
Methanol VWR Cat# 20846.326 
METTL1/WDR4 Recombinant complex Evotec (Ad hoc 
preparation) 
MgCl2 Sigma-Aldrich Cat# M-0250 
N-(aminooxyacetyl)-N’-(D-Biotinoyl) hydrazine Thermo Fisher Cat# A10550 
NaCl Sigma-Aldrich Cat# S7653 
NheI NEB Cat# R3131S 
NotI NEB Cat# R3189S 
NP40 Sigma-Aldrich Cat# I3021 
Phenylmethanesulfonyl fluoride Sigma-Aldrich Cat# P7626 
Phosphocreatine disodium salt hydrate Sigma-Aldrich Cat# P7936 
Phosphodiesterase 1 Sigma-Aldrich Cat# P3243-1VL 
Polybrene Sigma-Aldrich Cat# 107689 
Protease Inhibitor Complete tablets, EDTA-free Roche Cat# 11836170001 
Proteinase K NEB Cat# P8107S 
Puromycin Invivogen Cat# ant-pr-1 
Qiazol Qiagen Cat# 79306 
RNAse A Thermo Fisher Cat# EN0531 
RnaseOUT Ribonuclease Inhibitor Thermo Fisher Cat# 10777019 
RNAsin Plus Ribonuclease Inhibitor Promega Cat# N2611 
S-Adenosyl-Methionine NEB Cat# B9003S 
Sodium borohydride Sigma-Aldrich Cat# 480886 
Sodium dodecyl sulfate ICN Cat# 811030  
Sodium hydroxide Sigma-Aldrich Cat# S8045 
Spermidine trihydrochloride Sigma-Aldrich Cat# S2501  
Sucrose Fisher Scientific Cat#S/8600/60 
Triethylamine VWR Cat# 84883.180 
TRIS Base Melford Cat# T60040-
1000.0 
Triton X-100 Sigma-Aldrich Cat# X100  
Tween-20 Sigma-Aldrich Cat# P1379  
Uridine-13C9,15N2 5′-triphosphate Sigma-Aldrich Cat# 645672-1MG 
XbaI NEB Cat# R0145S 
[α-32P]-GTP / 3000Ci/mmol - 10mCi/ml Perkin-Elmer Cat# 
BLU006H250UC 
Critical Commercial Assays 
Agilent SurePrint G3 Human Gene Expression 
Array v3 (8x60K) 
Agilent Technologies Cat# G4851C 
Dual-Glo Luciferase Assay System Promega Cat# E2920 
ECL Prime detection reagent kit GE Healthcare Cat# RPN2232 
Fast SybrGreen PCR mastermix Applied Biosystems Cat# 4385612 
High-capacity cDNA reverse transcription kit Applied Biosystems Cat# 4368814 
Low Input QuickAmp Labeling Kit, One-Color Agilent Technologies Cat# 5190-2305 
miRNEasy mini kit Qiagen Cat# 217004 
miScript II RT kit Qiagen Cat# 218161 
NEBNext SmallRNA kit NEB Cat# E7300S 
Qubit dsDNA HS Assay Kit  Thermo Fisher Cat# Q32851 
Qubit RNA HS Assay Thermo Fisher Cat# Q32852 
RNA Clean & Concentrator - 25 Zymo Cat# R1017 
RNA Clean & Concentrator - 5 Zymo Cat# R1013 
RNeasy MinElute Cleanup Kit Qiagen Cat# 74204 
SuperScript III Reverse Transcriptase Thermo Fisher Cat# 18080044 
Tapestation RNA ScreenTape Agilent Technologies Cat# 5067-5576 
Taqman Advanced miRNA cDNA Synthesis Kit Thermo Fisher Cat# A28007 
TaqMan Fast Advanced Master Mix Applied Biosystems Cat# 4444556 
TaqMan™ Advanced miRNA Assay (A25576) Thermo Fisher Listed in Table S8 
TranscriptAid T7 High Yield Kit Thermo Fisher Cat# K0441 
Universal ProbeLibrary (4683633001) Roche Listed in Table S8 
Deposited Data 
METTL1 Knock-down Expression Microarray data This study GEO: GSE112180 
BoRed-seq and m7G-RIP-seq in A549 This study GEO: GSE112181 
m7G-RIP-Seq in Caco-2 This study GEO: GSE120454 
m7G-RIP-Seq in A549 METTL1 Knock-down This study GEO: GSE120455 
Unprocessed imaging data  This study doi: 10.17632/ 
yscng45zgj.1 
Experimental Models: Cell Lines 
HEK-293T (Human embryonic kidney) ATCC RRID: CVCL_0063 
A549 (Human lung adenocarcinoma) ATCC RRID: CVCL_0023 
Caco-2 (Human colorectal adenocarcinoma) ATCC RRID: CVCL_0025 
Oligonucleotides 
DNA and RNA oligonucleotides are listed in Table 
S8 
This study N/A 
GFP MISSION esiRNAs Sigma-Aldrich Cat# EHUEGFP-
50UG 
METTL1 MISSION esiRNAs Sigma-Aldrich Cat# EHU076851-
50UG 
miRIDIAN Control miRNA mimic Dharmacon Cat# CN-001000-
01-05 
miRIDIAN hsa-let-7e-5p miRNA mimic Dharmacon Cat# C-300479-
05-0002 
Recombinant DNA 
Hmga2-Luc-m7 Addgene #14788 
Hmga2-Luc-wt Addgene #14785 
PAX2 Addgene #12260 
pcDNA3-pri-let-7e Addgene #51380 
pcDNA4/TO/cmycDrosha Addgene #10828 
pHIV-ZsGreen Addgene #18121 
pLKO-TETon-Puro Addgene #21915 
pMD2.G Addgene #12259 
pMirGlo Promega Cat# E1330 
Software and Algorithms 
Bioconductor (https://www.bioconductor.org/) N/A 




featureCounts (Liao et al., 2014) N/A 
G4Hunter (Bedrat et al., 2016) N/A 
Gage (Luo et al., 2009) N/A 
gbm (Freund and Schapire, 1997) N/A 
limma (Smyth et al., 2005) N/A 
miRWalk 2.0 (Dweep and Gretz, 2015) N/A 
Pathwiew (Luo et al. 2017) N/A 
Quadparser (Huppert and 
Balasubramanian, 2005) 
N/A 
R statistical environment (https://www.r-project.org/) N/A 
RNAfold (Lorenz et al. 2011) N/A 
STAR (Dobin et al., 2013) N/A 
Sylamer (van Dongen et al., 2008) N/A 
Trimmomatic (Bolger et al., 2014) N/A 
Feature Extraction Software Agilent Technologies G4463AA 
XCalibur Thermo Fisher OPTON-30487 
Other 
ACQUITY UPLC HSS T3 Column Waters Corp Cat# 186005614 
Amicon 30kDa MWCO spin-column Merck Millipore Cat# Z717185 
Amersham Hybond-C Extra Nitrocellulose 
membrane 
GE Healthcare Cat# RPN203D 
Amersham Hybond-N+ Nylon Membrane GE Healthcare Cat# RPN2020B 
Amersham Hyperfilm HS autoradiography film GE Healthcare Cat# 28906836 
Bradford assay Bio-Rad Cat# 5000006 
Denhart’s solution Thermo Fisher Cat# 750018 
Dulbecco’s Modified Essential Medium Gibco Cat# 41965-039 
Dynabeads MyOne Streptavidin C1 Thermo Fisher Cat# 65001 
Dynabeads Protein G Thermo Fisher Cat# 10004D 
Eagle’s Modified Essential Medium Sigma-Aldrich Cat# M2279 
Fetal Bovine Serum Gibco Cat# 10270-106 
Illustra MicroSpin G-25 spin column GE Healthcare Cat# 27532501 
Migration assay transwell inserts (8 μm) Corning Cat# 3422 
Novex TBE 6% precast gel Thermo Fisher Cat# EC6265BOX 
Novex TBE-Urea 10% precast gel Thermo Fisher Cat# EC6875BOX 
Novex TBE-Urea 15% precast gel Thermo Fisher Cat# EC6885BOX 
Novex TBE-Urea 6% precast gel Thermo Fisher Cat# EC6865BOX 
Novex TBE-Urea Sample Buffer Thermo Fisher Cat# LC6876 
Penicillin/Streptomycin/Glutamine Gibco Cat# 10378016 
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KEGG pathway stat.mean p.val
hsa04360 - Axon guidance 2.4876 0.0068
hsa03010 - Ribosome 2.3188 0.0110
hsa04340 - Hedgehog signaling pathway 2.2496 0.0134
hsa04510 - Focal adhesion 2.1274 0.0170
hsa04512 - ECM-receptor interaction 2.0395 0.0216
hsa04310 - Wnt signaling pathway 1.8033 0.0363
hsa04115 - p53 signaling pathway 1.7812 0.0388
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|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |─
2xDAG
GGGCUGAGGUAGGAGGUUGUAUAGUU
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |─
D1
GGGCUGAGGUAGGAGGUUGUAUAGUU
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(m7G)
GGGCUGAGGUAGGAGGUUGUAUAGUU
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Figure S1 | High-throughput profiling of m7G modification in miRNAs. Related to Figure 1. 
A, Schematic  representation  (top)  of  the  expected  cleavage  of  18S rRNA  after  NaBH4  +  aniline  treatment  and
electropherogram analysis (bottom) of untreated and treated total RNA from A549 cells.  B, Immunoprecipitation with anti-
m7G antibody  does  not  enrich  RNAs  containing  five  different  guanine  modifications  (including  four  methylations)  as
determined by mass spectroscopy. Error bars represent S.E.M. C, HPLC trace of the four canonical RNA nucleosides along
with  7-methylguanosine,  showing  retention  times  that  are  an  exact  match  with  pure  nucleosides  run  as  quantitation
standards. D, Extracted ion chromatogram of 7-methylguanosine, with the accompanying mass spectra showing the intact
protonated  precursor  ion of  the nucleoside [M+H]  (middle  panel)  and the 7-methylguanine  ion generated  by in-source
fragmentation as an internal verification of its identity.
Supplemental Material PDF
Figure S2
Figure S2 | Validation of BoRed-Seq and m7G-RIP-Seq. Related to Figure 1. 
A, Electropherogram analyses of total RNA before and after immunoprecipitation with an m7G-specific antibody showing
specific enrichment for 18S rRNA in the immunoprecipitate. B, Read counts for tRNAs from the BoRed-Seq and m7G-RIP-
Seq experiments are shown.  Error bars represent S.E.M. C,  Venn diagram showing the high overlap between miRNAs
significantly enriched in either m7G-RIP-Seq or BoRed-Seq of A549 cells, respectively. Confidence interval of the odds ratio
(OR) and P-value, as obtained by Fisher’s exact test, are indicated in the table below.  D, Read counts for the indicated
miRNA from the BoRed-Seq and RIP-Seq experiments are shown. Error bars represent S.E.M. E, Scatter plot showing the
absence of correlation between m7G and miRNA expression levels. Labels show the m7G containing miRNAs amongst the
top 20 most expressed ones and their absolute ranking.  F,  Scatter plot of  m7G-RIP-Seq miRNA enrichment in Caco-2
versus  A549  cells,  highlighting  a  high  degree  of  correlation,  as  indicated  by  R2  Pearson  correlation  coefficient.  G,
Immunoblot using an m7G-specific antibody shows a reduction of m7G levels in tRNAs upon  METTL1 knockdown. Right
graph  shows  the  average  ±  S.E.M. digital  quantification  of  the  m7G signal  (*P<0.05,  two  tailed  t-test).  H, RT-qPCR
quantification  of  let-7e-5p, miR-125a-5p and  miR-148a-3p upon  METTL1 KD  in  Caco-2  cells.  The  average  of  four
independent biological replicates ± S.D. is shown (**P<0.01, two tailed t-test). I, Crystal structure of METTL1 in complex with
S-adenosylmethionine (PDB file: 3CKK). The EIR (107-109) amino acids mutated to alanine to generate the catalytically
inactive mutant are shown in red. J, RNA immunoblot with an m7G-specific antibody on total RNA from METTL1 knockdown
or control  cells over-expressing either  WT METTL1 or a catalytically  inactive METTL1 (c.i.).  K, Polysome fractionation
analysis. Cell extracts from control or METTL1 knockdown cells were prepared and resolved in a 5–50% sucrose gradient.
The absorbance at 254 nm was continuously measured. The peaks corresponding to free 40S and 60S subunits, 80S and
polysomes are indicated. Shaded area in grey indicates the S.E.M. of two independent samples for each condition.
Figure S3
Figure S3 | Effects of targeting METTL1 in A549 cells. Related to Figure 2. 
A, migration assay of A549 cells.  Increased migration due to METTL1 KD is rescued by the expression of WT METTL1 (+),
but  not  by  a  catalytically  inactive  version  of  the  enzyme (c.i.).  B,C,D,E,  Graphical  representation  of  KEGG pathway
regulation,  showing  up-regulation  of  ECM-receptor  interaction (B),  adherens  junction (C),  axon guidance (D)  and focal
adhesion (E).  Data  were  obtained by comparing  RNA expression data  from  METTL1  KD and control  A549 cells  (up-
regulated genes, red; down-regulated genes, green). F, Sylamer miRNA target seed motif analysis on up-regulated mRNAs
upon METTL1 KD, showing a specific enrichment for the let-7 (5p) seed motif. G, representative cell migration genes whose
expression is upregulated upon METTL1 KD, which are targets of let-7e-5p, miR-125a-5p or both (for all of them FDR<0.05,
as evaluated with limma). H, A gradient boosting classifier was used to model the mRNA expression fold changes observed
by microarray analysis as a function of the presence of seed sites for different miRNAs in 3'-UTRs. Receiver operating
characteristic (ROC) curve displays the goodness of the model, with an area under ROC (AUC) of 0.68. The presence of let-
7 (5p) seed sequence within an mRNA represents the strongest predictive factor for its up-regulation upon METTL1 KD, as
shown by the top 20 predictor list. The marginal effect plot shows that there is a positive correlation between the number of
seeds in the 3'-UTR and mRNA up-regulation.
Figure S4
Figure S4 | miRNA processing is dependent on m7G. Related to Figure 3 and 4. 
A, HMGA2 expression measured by RT-qPCR in Caco-2 cells infected with METTL1-specific or control (Scr) TET-inducible
shRNAs five days after doxycycline treatment. The average of five biological replicates ± S.D. is shown (***p<0.001, two
tailed t-test). B, Western blot showing METTL1, HMGA2 and β-tubulin protein levels in Caco-2 cells infected with METTL1-
specific or control (Scramble) TET-inducible shRNAs five days after doxycycline treatment. Two representative biological
replicates of a total of four are shown. C, BoRed and m7G-RIP coupled to RT-qPCR of HMGA2 in A549 cells. 18S rRNA is
used as a positive control; GAPDH is a negative control. let-7e-5p levels are replotted alongside as a positive reference. The
average of three biological and technical replicates ± S.E.M. are shown. D, Western blot showing METTL1 down-regulation
upon transfection with  METTL1 specific siRNAs in A549 cells stably expressing a luciferase cDNA with a  Hmga2-3'-UTR
with mutated let-7 seed sites. Two independent transfections of a total of four replicates are shown. E, CLIP-qPCR using a
METTL1-specific antibody or a non-specific IgG. The levels of immunoprecipitated miR-148a primary hairpin are shown. The
average of two independent immunoprecipitation reactions ± S.E.M. is presented (*P<0.05, two tailed t-test).  F, RT-qPCR
showing the levels of miR-148a-3p upon METTL1 KD in A549 cells. The average of five independent biological replicates ±
S.D. is shown. G, Western blot of DICER, DGCR8 and ARGONAUTE (pan-AGO) upon METTL1 KD in A549 cells. H, Box
plots visualizing the normalized smallRNA-Seq counts of INPUT and m7G-RIP miRNAs from either control (Scr) or METTL1
KD A549 cells.  I, m7G RNA immunoprecipitation and RT-qPCR of  LET7A3,  LET7B,  LET7E/125A  and MIR23B primary
transcripts in A549 cells.  MIR148A is shown as a negative control.  J, m7G-RIP and RT-qPCR of  MIR23B and MIR148A
primary transcripts upon  METTL1 KD in A549 cells. The average of three independent biological replicates ± S.E.M. is
shown (*P<0.05, **P<0.01, ***P<0.001, two tailed t-test).
Figure S5
Figure S5 | METTL1-mediated miRNA methylation. Related to Figure 4 and 5. 
A, Autoradiography and digital  quantification of the results from in vitro processing of a radioactively labelled  pri-let-7e
incubated with cell extracts from control (Ctrl) or METTL1 KD A549 cells. The average of three independent experiments ±
S.D. is shown (*P<0.05, **P<0.01, two tailed t-test). Autoradiography images are composite of different molecular weight
regions  and  exposure  times.  Full,  unprocessed  images  are  deposited  on  Mendeley  Data.  B, Coomassie  staining  and
Western blot of co-expressed recombinant 6xHis-tagged METTL1 and FLAG-tagged WDR4 from baculovirus-infected insect
cells. C, In vitro methylation reaction using recombinant METTL1/WDR4 pre-assembled complex on pre-tRNAPhe or a hairpin
shRNA targeting GFP (negative control). Mass spectrometry analysis shows specific m7G methylation of pre-tRNA Phe. D,E,
Representative extracted ion chromatograms of collated charge states of unmodified (left chromatogram) and methylated
AGGAGGU (right chromatogram) oligonucleotides. Precursor ion areas were quantified from technical triplicates (quantified
area shown in grey). Chromatograms shown are from a single replicate.  E, in vitro methylation reaction using recombinant
METTL1/WDR4 pre-assembled complex on WT and G11-DAG let-7 oligonucleotides.
Figure S6
Figure S6 | m7G modified miRNAs are prone to G-quadruplex formation. Related to Figure 5. 
A, Box plot showing the base content in primary hairpins of either unmodified or m7G containing miRNAs (P-values are
calculated with Wilcoxon test).  B, Proportion of G-quadruplex forming motifs detected within  primary hairpins of either
unmodified or m7G containing miRNAs (see STAR Methods for details; *P<0.05, **P<0.01, ***P<0.001; Fisher’s exact test).
C, Circular dichroism (CD) of the minimal rG4-let-7e sequence reveals that its structure is cation-dependent and its spectra
display a minimum and maximum at 240 and 263 nm, respectively. These are feature of G-quadruplex formation. The
stability of rG4-let-7e WT structure is cation-dependent, with a thermal stability (Tm) of 48.1 °C in the presence of 100 mM
KCl. While G11 to DAG substitution in rG4-let-7e DAG does not completely abolishes rG4 formation, it greatly destabilizes it.
The thermal stability decreases from 48.1 °C to 35.5 °C in the presence of 100 mM KCl and the oligonucleotide is no longer
folded in the presence of LiCl or NaCl. D, CD spectra of pri-let-7e hairpin. The minimum at 210 nm indicates the expected
stem-loop structure. E, Cartoon depicting the pri-miRNA hairpins employed in the following panel. F, Thermal denaturation
studies of GG to AA mutants at the D1 or D2 position, supporting the formation of a G-quadruplex within pri-let-7e. Melting
profiles of both mutants display a single transition at high temperature characteristic of the canonical hairpin structure. The
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Table S8










































qPCR Taqman Advanced miRNA Assay Ids (Thermo Fisher Cat# A25576)
hsa-let-7e-5p 478579_mir
hsa-miR-125a-5p 477884_mir
hsa-miR-196a-5p 478230_mir
hsa-miR-375 478074_mir
hsa-miR-148a-3p 477814_mir
hsa-miR-381-3p 477816_mir
hsa-mir-101-3p 477863_mir
RNA Oligonucleotides
pre-Phe-tRNA GCGGAUUUAGCUCAGUUGGGAGAGCGCCAGACUGAAGAAAAAACUUCGGUCAAGUUAUCUGGAGGUCCUGUGUUCGAUCCACAGAAUUCGCACCA
cel-miR-67 CGUCGAUCCGCUCAUUCUGCCGGUUGUUAUGCUAUUAUCAGAUUAAGCAUCACAACCUCCUAGAAAGAGUAGAUCGAUU
pri-let-7e WT CCCGGGCUGAGGUAGGAGGUUGUAUAGUUGAGGAGGACACCCAAGGAGAUCACUAUACGGCCUCCUAGCUUUCCCCAGG
pri-let-7e AAmutD1 CCCGGGCUGAAAUAGGAGGUUGUAUAGUUGAGGAGGACACCCAAGGAGAUCACUAUACGGCCUCCUAGCUUUCCCCAGG
pri-let-7e AAmutD2 CCCGGGCUGAGGUAGGAAAUUGUAUAGUUGAGGAGGACACCCAAGGAGAUCACUAUACGGCCUCCUAGCUUUCCCCAGG
CCCGGGCUGA**UAGGAGGUUGUAUAGUUGAGGAGGACACCCAAGGAGAUCACUAUACGGCCUCCUAGCUUUCCCCAGG
CCCGGGCUGAGGUAGGA**UUGUAUAGUUGAGGAGGACACCCAAGGAGAUCACUAUACGGCCUCCUAGCUUUCCCCAGG
CCCGGGCUGAGGUAGGA*GUUGUAUAGUUGAGGAGGACACCCAAGGAGAUCACUAUACGGCCUCCUAGCUUUCCCCAGG
rG4-let-7e WT GGGCUGAGGUAGGAGG
GGGCUGAGGUAGGA*G
METTL1 sh1 CCGGATGACCCAAAGGATAAGAAACTCGAGTTTCTTATCCTTTGGGTCATCTTTTTG
METTL1 sh2 CCGGCCCACATTTCAAGCGGACAAACTCGAGTTTGTCCGCTTGAAATGTGGGTTTTTG
CCGGCAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTCATCTTGTTGTTTTTG
METTL1 cDNA
METTL1 WT
CACACTGGCGGCCGCACCATGGCAGCCGAGACTCGGAACGTGGCCGGAGCAGAGGCCCCACCGCCCCAGAAGCGCTACTACCGGCAACGTGCTCACTCCAACCC
CATGGCGGACCACACGCTGCGCTACCCTGTGAAGCCAGAGGAGATGGACTGGTCTGAGCTATACCCAGAGTTCTTCGCTCCACTCACTCAAAATCAGAGCCACG
ACGATCCTAAAGACAAAAAAGAAAAGAGAGCTCAGGCCCAAGTGGAGTTTGCAGACATAGGCTGTGGCTATGGTGGCCTGTTAGTGGAACTGTCACCGCTGTTC
CCAGACACACTTATTCTGGGTCTGGAGATCCGGGTGAAGGTCTCAGACTATGTACAAGACCGGATTCGGGCCCTACGCGCAGCTCCTGCAGGTGGCTTCCAGAA
CATCGCCTGTCTCCGTAGCAATGCCATGAAGCACCTTCCTAACTTCTTCTACAAGGGCCAGCTGACAAAGATGTTCTTCCTCTTCCCCGATCCCCACTTTAAAC
GCACAAAGCACAAGTGGCGAATCATCAGTCCCACCCTGCTAGCAGAAT
METTL1 EIR/AAA Mut
CACACTGGCGGCCGCACCATGGCAGCCGAGACTCGGAACGTGGCCGGAGCAGAGGCCCCACCGCCCCAGAAGCGCTACTACCGGCAACGTGCTCACTCCAACCC
CATGGCGGACCACACGCTGCGCTACCCTGTGAAGCCAGAGGAGATGGACTGGTCTGAGCTATACCCAGAGTTCTTCGCTCCACTCACTCAAAATCAGAGCCACG
ACGATCCTAAAGACAAAAAAGAAAAGAGAGCTCAGGCCCAAGTGGAGTTTGCAGACATAGGCTGTGGCTATGGTGGCCTGTTAGTGGAACTGTCACCGCTGTTC
CCAGACACACTTATTCTGGGTCTGGCGGCAGCCGTGAAGGTCTCAGACTATGTACAAGACCGGATTCGGGCCCTACGCGCAGCTCCTGCAGGTGGCTTCCAGAA
CATCGCCTGTCTCCGTAGCAATGCCATGAAGCACCTTCCTAACTTCTTCTACAAGGGCCAGCTGACAAAGATGTTCTTCCTCTTCCCCGATCCCCACTTTAAAC
GCACAAAGCACAAGTGGCGAATCATCAGTCCCACCCTGCTAGCAGAAT
pri-let-7e D1 (*=DAG)
pri-let-7e D2 (*=DAG)
pri-let-7e G11 (*=DAG)
rG4-let-7e DAG (*=DAG)
